0001506929false--06-30Q220260.0015000000000000.0011000000000012626808911294224767falsefalsefalsefalse000000000000000000000000.200.1037500067000010000000.07there were one (1) single customer respectively whose revenue exceeded 10% of the revenue50000135000010000000.05C-Twelve a royalty equal to three percent (3%) of all future carbon removal credits generated through the use of Verde-C12 IPs, and to provide a loan to C-Twelve in an amount not less than USD $2,000,000 (the “C-Twelve Loan”), with interest accruing at the lowest applicable federal rate, within 30 days00015069292025-07-012025-12-310001506929us-gaap:SubsequentEventMembervrdr:EricBavaMembervrdr:PeriodFromOctoberTwoThousandTwentyFiveToSeptemberTwoThousandTwentySixMember2026-01-012026-01-050001506929us-gaap:SubsequentEventMembervrdr:PeriodFromMayOneTwoThousandTwentyFiveToMayOneTwoThousandTwentySixMembervrdr:DaleLudwigMember2026-01-012026-01-050001506929us-gaap:SubsequentEventMembervrdr:HannahBruehlMembervrdr:PeriodFromSeptemberThreeTwoThousandTwentyFiveTSeptemberTwoTwoThousandTwentySixMember2026-01-012026-01-050001506929us-gaap:SubsequentEventMember2026-02-012026-02-100001506929us-gaap:SubsequentEventMembervrdr:PeriodFromMayOneTwoThousandTwentyFiveToMayOneTwoThousandTwentySixMembervrdr:NamTranMember2026-01-012026-01-0500015069292025-12-012025-12-230001506929vrdr:ServiceandStockCancellationAgreementMember2025-12-310001506929vrdr:PeriodFromJulyTwoThousandTwentyFiveToSeptemberTwoThousandTwentySixMembervrdr:NationalCenterAsphaltTechnologyMember2025-07-012025-12-310001506929vrdr:ServiceandStockCancellationAgreementMember2024-11-290001506929vrdr:EricBavaMember2025-12-310001506929vrdr:FYETwoThousandTwentySevenMember2025-07-012025-12-310001506929vrdr:FYETwoThousandTwentySevenMembervrdr:DaleLudwigMember2025-07-012025-12-310001506929vrdr:FYETwoThousandTwentySevenMembervrdr:RaymondPowellMember2025-07-012025-12-310001506929vrdr:FYETwoThousandTwentySevenMembervrdr:NamTranMember2025-07-012025-12-310001506929vrdr:FYETwoThousandTwentySixMember2025-07-012025-12-310001506929vrdr:FYETwoThousandTwentySixMembervrdr:DaleLudwigMember2025-07-012025-12-310001506929vrdr:FYETwoThousandTwentySixMembervrdr:NamTranMember2025-07-012025-12-310001506929vrdr:AgreementWithJeremyPConcannonMember2025-07-012025-12-310001506929vrdr:AgreementWithDaleLudwigMember2025-07-012025-12-310001506929vrdr:AgreementWithDrNamTranAndDrRaymondPowellMember2025-07-012025-12-310001506929vrdr:AgreementWithDonaldRFosnachtMember2025-07-012025-12-310001506929vrdr:AgreementWithLooiPeiSeeMember2025-07-012025-12-310001506929vrdr:AgreementWithAUMMediaIncMember2024-11-012024-11-290001506929vrdr:CTwelvePtyLtdMember2024-10-012024-10-180001506929vrdr:AgreementWithAUMMediaIncMember2025-07-012025-12-310001506929vrdr:AgreementWithJeremyPConcannonMember2024-07-012024-07-310001506929vrdr:AgreementWithEricBavaMember2025-07-012025-12-310001506929vrdr:AgreementWithDaleLudwigMember2024-05-312024-06-010001506929vrdr:AgreementWithDrNamTranAndDrRaymondPowellMember2024-04-012024-04-200001506929vrdr:AgreementWithDonaldRFosnachtMember2023-10-012023-10-230001506929vrdr:AgreementWithLooiPeiSeeMember2022-12-012022-12-150001506929vrdr:AgreementWithEricBavaMember2024-04-200001506929vrdr:AgreementWithDonaldRFosnachtMember2023-10-230001506929vrdr:AgreementWithLooiPeiSeeMember2022-12-150001506929vrdr:AgreementWithDrNamTranAndDrRaymondPowellMember2024-07-310001506929vrdr:AgreementWithDrNamTranAndDrRaymondPowellMember2025-12-310001506929vrdr:AgreementWithJeremyPConcannonMember2025-12-310001506929vrdr:AgreementWithDaleLudwigMember2024-06-010001506929vrdr:AgreementWithDrNamTranAndDrRaymondPowellMember2024-04-200001506929vrdr:AgreementWithEricBavaMember2025-12-310001506929vrdr:AgreementWithEricBavaMember2024-08-300001506929vrdr:AgreementWithHannahBruehlExecutiveAssistantToCSuiteExecutivesMember2025-12-310001506929vrdr:KarlStrahlMember2025-12-310001506929vrdr:CTwelvePtyLtdMember2024-10-180001506929vrdr:AgreementWithHannahBruehlExecutiveAssistantToCSuiteExecutivesMember2025-01-030001506929vrdr:AgreementWithHannahBruehlExecutiveAssistantToCSuiteExecutivesMember2024-06-300001506929vrdr:AgreementWithAUMMediaIncMember2024-11-290001506929vrdr:AgreementWithHannahBruehlExecutiveAssistantToCSuiteExecutivesMember2025-09-020001506929vrdr:AgreementWithJeremyPConcannonMember2024-07-310001506929vrdr:AgreementWithHannahBruehlExecutiveAssistantToCSuiteExecutivesMember2025-07-012025-12-310001506929vrdr:CTwelvePtyLtdMember2025-07-012025-12-310001506929vrdr:KarlStrahlMember2025-07-012025-12-310001506929us-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-12-310001506929us-gaap:ShareBasedPaymentArrangementNonemployeeMember2024-07-012025-06-300001506929us-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-07-012025-12-310001506929us-gaap:ShareBasedPaymentArrangementNonemployeeMember2024-06-300001506929us-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-06-300001506929us-gaap:ShareBasedPaymentArrangementEmployeeMember2025-12-310001506929us-gaap:ShareBasedPaymentArrangementEmployeeMember2025-07-012025-12-310001506929us-gaap:ShareBasedPaymentArrangementEmployeeMember2024-07-012025-06-300001506929us-gaap:ShareBasedPaymentArrangementEmployeeMember2025-06-300001506929us-gaap:ShareBasedPaymentArrangementEmployeeMember2024-06-300001506929vrdr:VendorMember2025-07-012025-12-310001506929vrdr:MajorCustomersMember2025-07-012025-12-310001506929vrdr:VendorMember2024-07-012024-12-310001506929vrdr:MajorCustomersMember2024-07-012024-12-310001506929vrdr:VendorAMember2025-07-012025-12-310001506929vrdr:VendorAMember2025-12-310001506929vrdr:VendorAMember2025-06-300001506929vrdr:VendorAMember2024-07-012024-12-310001506929vrdr:CustomerAMember2025-06-300001506929vrdr:CustomerBMember2025-06-300001506929vrdr:CustomerBMember2025-07-012025-12-310001506929vrdr:CustomerBMember2025-12-310001506929vrdr:CustomerAMember2025-07-012025-12-310001506929vrdr:CustomerBMember2024-12-310001506929vrdr:CustomerAMember2024-12-310001506929vrdr:CustomerAMember2025-12-310001506929vrdr:CustomerBMember2024-07-012024-12-310001506929vrdr:CustomerAMember2024-07-012024-12-310001506929vrdr:BorneoOilCorporationSdnBhdBOCMember2025-07-012025-12-310001506929vrdr:BOCTwoMember2024-07-012024-12-310001506929vrdr:BOCTwoMember2025-07-012025-12-310001506929vrdr:MrJackWongMember2024-07-012024-12-310001506929vrdr:MrJackWongMember2025-07-012025-12-310001506929vrdr:MrTeoZyeKeunMember2024-07-012024-12-310001506929vrdr:MrTeoZyeKeunMember2025-07-012025-12-310001506929vrdr:SBResortsSdnBhdMember2024-07-012024-12-310001506929vrdr:SBResortsSdnBhdMember2025-07-012025-12-310001506929vrdr:MalaysiyaTerritoryMember2025-12-310001506929vrdr:USTaxRegimeMember2025-07-012025-12-310001506929vrdr:MalaysiyaTerritoryMember2025-07-012025-12-310001506929vrdr:LabuanMember2025-07-012025-12-310001506929vrdr:MalaysiaTaxRegimeMember2025-12-310001506929vrdr:MalaysiaTaxRegimeMember2025-06-300001506929vrdr:USTaxRegimeMember2025-12-310001506929vrdr:USTaxRegimeMember2025-06-300001506929vrdr:ForeignincludingLabuanMalaysiaMember2024-07-012024-12-310001506929vrdr:ForeignincludingLabuanMalaysiaMember2025-07-012025-12-310001506929vrdr:ForeignincludingMalaysiaMember2025-07-012025-12-310001506929vrdr:ForeignincludingMalaysiaMember2024-07-012024-12-310001506929vrdr:ForeignincludingBritishVirginIslandMember2025-07-012025-12-310001506929vrdr:ForeignincludingBritishVirginIslandMember2024-07-012024-12-310001506929vrdr:LocalUSRegimeMember2025-07-012025-12-310001506929vrdr:LocalUSRegimeMember2024-07-012024-12-310001506929vrdr:CommonShareMember2025-10-012025-12-310001506929vrdr:CommonShareMember2024-10-012024-12-310001506929vrdr:CommonShareMember2025-07-012025-12-310001506929vrdr:CommonShareMember2024-07-012024-12-310001506929vrdr:JulyThirtyOneTwoThousandTwentyFourMembervrdr:RaymondPowellMember2024-07-012024-07-310001506929vrdr:BorneoOilCorporationSdnBhdBOCMember2024-08-160001506929vrdr:ServiceandStockCancellationAgreementMember2023-09-080001506929vrdr:TwoUSShareholderMember2024-09-160001506929vrdr:TwentyThreeAndOneNonUSShareholderMember2024-08-090001506929vrdr:TwoUSShareholderMember2024-11-012024-11-270001506929vrdr:OneUSShareholderMember2025-04-012025-04-220001506929vrdr:PromissoryNoteMember2024-08-1600015069292023-03-1300015069292024-08-160001506929us-gaap:RestrictedStockMember2023-10-230001506929vrdr:ThreeUSShareholdersMember2024-08-012024-08-260001506929vrdr:KarlStrahlMember2025-05-252025-06-010001506929vrdr:SundeoPtyLtdMember2025-05-252025-06-010001506929vrdr:MayTwentyTwoThousandTwentyFiveMembervrdr:OneUSAndOneNonUSShareholderMember2025-05-012025-05-200001506929vrdr:USshareholdersMember2025-02-012025-02-180001506929vrdr:OneUSShareholderMember2025-02-012025-02-180001506929vrdr:SixAndTwoNonUSShareholderMember2025-02-012025-02-1800015069292025-02-012025-02-1800015069292025-01-012025-01-060001506929vrdr:AegisVenturesLimitedMember2024-08-012024-08-260001506929vrdr:AegisVenturesLimitedMember2025-01-012025-01-020001506929vrdr:SixAndTwoNonUSShareholderMember2025-01-012025-01-020001506929vrdr:ThreeUSShareholdersMember2025-01-012025-01-020001506929vrdr:OctoberSixteenTwoThousandTwentyFourMembervrdr:ThreeUSShareholdersMember2025-07-012025-12-310001506929vrdr:TwoUSShareholderMember2024-09-012024-09-160001506929vrdr:OneUSShareholderMember2024-09-012024-09-160001506929vrdr:AugustThirtyTwoThousandTwentyFourMembervrdr:EricBavaMember2024-08-012024-08-300001506929vrdr:AugustThirtyTwoThousandTwentyFourMembervrdr:JeremyPConcanonMember2024-08-012024-08-300001506929vrdr:SixAndTwoNonUSShareholderMember2024-08-012024-08-260001506929vrdr:PromissoryNoteMember2024-08-012024-08-1600015069292024-08-012024-08-160001506929vrdr:TwentyThreeAndOneNonUSShareholderMember2024-08-012024-08-090001506929vrdr:OneUSShareholderMember2024-08-012024-08-090001506929vrdr:JulyTwentyFourTwoThousandTwentyFourMembervrdr:TwentyAndOneUSShareholderMember2024-07-012024-07-240001506929vrdr:JulyTwentyFourTwoThousandTwentyFourMembervrdr:FourUSShareholdersMember2024-07-012024-07-240001506929vrdr:AugustEightTwoThousandTwentyFourMembervrdr:DaleLudwigMember2024-08-012024-08-080001506929vrdr:JulyThirtyFirstTwoThousandTwentyFourMembervrdr:DrNamTranMember2024-07-012024-07-310001506929vrdr:ServiceandStockCancellationAgreementMember2024-09-012024-09-080001506929vrdr:MayTwentyTwoThousandTwentyFiveMembervrdr:OneUSAndOneNonUSShareholderMember2025-05-200001506929vrdr:USshareholdersMember2025-02-180001506929vrdr:SixAndTwoNonUSShareholderMember2025-02-180001506929vrdr:OneUSShareholderMember2025-02-180001506929vrdr:SixAndTwoNonUSShareholderMember2025-01-020001506929vrdr:ThreeUSShareholdersMember2025-01-020001506929vrdr:OctoberSixteenTwoThousandTwentyFourMembervrdr:ThreeUSShareholdersMember2025-12-310001506929vrdr:OneUSShareholderMember2024-09-160001506929vrdr:SixAndTwoNonUSShareholderMember2024-08-260001506929vrdr:ThreeUSShareholdersMember2024-08-260001506929vrdr:ThreeNonUSshareholderMember2025-09-012025-09-120001506929vrdr:NonUSshareholderMember2024-08-160001506929vrdr:OneUSShareholderMember2025-07-012025-07-280001506929vrdr:OneUSShareholderMember2024-08-090001506929vrdr:ThreeNonUSshareholderMember2025-06-262025-07-020001506929vrdr:JulyTwentyFourTwoThousandTwentyFourMembervrdr:TwentyAndOneUSShareholderMember2024-07-240001506929vrdr:NonUSshareholderMember2025-06-262025-07-020001506929vrdr:JulyTwentyFourTwoThousandTwentyFourMembervrdr:FourUSShareholdersMember2024-07-2400015069292025-01-012025-01-030001506929vrdr:ServiceandStockCancellationAgreementMember2024-09-080001506929vrdr:ErgonPurchaseAgreementMember2025-10-012025-10-3100015069292025-10-012025-10-310001506929vrdr:TopMember2025-07-012025-12-310001506929vrdr:BottomMember2025-07-012025-12-310001506929vrdr:LeaseAssetAandLiabilitiesMember2025-06-300001506929vrdr:LeaseAssetAandLiabilitiesMember2025-12-310001506929vrdr:VetrolysisLimitedMember2025-12-310001506929vrdr:MrJackWongMember2025-12-310001506929vrdr:VetrolysisLimitedMember2025-06-300001506929vrdr:MrJackWongMember2025-06-300001506929vrdr:BorneoOilBerhadMember2025-12-310001506929vrdr:BorneoOilCorporationSdnMember2025-12-310001506929vrdr:VictoriaCapitalSdnBhdMember2025-12-310001506929vrdr:VictoriaCapitalSdnBhdMember2025-06-300001506929vrdr:BorneoEnergySdnBhdMember2025-12-310001506929vrdr:BorneoEnergySdnBhdMember2025-06-300001506929vrdr:BorneoEcoFoodSdnBhdMember2025-12-310001506929vrdr:SBSuppliesAndLogisticsSdnBhdMember2025-12-310001506929vrdr:SBResortsSdnBhdMember2025-12-310001506929vrdr:JAmbroseAndPartnersMember2025-12-310001506929vrdr:MakinTeguhSdnBhdMember2025-12-310001506929vrdr:TaipanInternationalLimitedMember2025-12-310001506929vrdr:BorneoEcoFoodSdnBhdMember2025-06-300001506929vrdr:SBSuppliesAndLogisticsSdnBhdMember2025-06-300001506929vrdr:SBResortsSdnBhdMember2025-06-300001506929vrdr:JAmbroseAndPartnersMember2025-06-300001506929vrdr:MakinTeguhSdnBhdMember2025-06-300001506929vrdr:TaipanInternationalLimitedMember2025-06-300001506929vrdr:BorneoOilBerhadMember2025-06-300001506929vrdr:BorneoOilCorporationSdnMember2025-06-300001506929us-gaap:LeaseAgreementsMember2022-03-020001506929us-gaap:LeaseAgreementsMember2022-03-012022-03-020001506929vrdr:FactorySiteMember2025-12-310001506929vrdr:FactorySiteMember2025-06-300001506929vrdr:VerdeRenewablesIncMember2024-07-270001506929us-gaap:VehiclesMember2025-06-300001506929us-gaap:VehiclesMember2025-12-310001506929us-gaap:LicenseMember2025-12-310001506929us-gaap:IntellectualPropertyMember2025-12-310001506929vrdr:FurnitureAndFittingsMember2025-06-300001506929vrdr:FurnitureAndFittingsMember2025-12-310001506929vrdr:MotorVehiclesMember2025-06-300001506929vrdr:MotorVehiclesMember2025-12-310001506929us-gaap:ComputerEquipmentMember2025-06-300001506929us-gaap:ComputerEquipmentMember2025-12-310001506929vrdr:RenovationMember2025-06-300001506929vrdr:RenovationMember2025-12-310001506929us-gaap:OfficeEquipmentMember2025-06-300001506929us-gaap:OfficeEquipmentMember2025-12-310001506929vrdr:PlantAndMachineryMember2025-06-300001506929vrdr:PlantAndMachineryMember2025-12-310001506929vrdr:OtherReceivablesMember2025-06-300001506929vrdr:OtherReceivablesMember2025-12-310001506929vrdr:TradingGoodsMember2025-12-310001506929vrdr:ManufacturedBioProduceMember2025-12-310001506929vrdr:TradingGoodsMember2025-06-300001506929vrdr:ManufacturedBioProduceMember2025-06-300001506929vrdr:BottomMember2025-06-300001506929vrdr:TopMember2025-06-300001506929vrdr:BottomMember2024-07-012025-06-300001506929vrdr:TopMember2024-07-012025-06-300001506929us-gaap:OperatingSegmentsMember2024-10-012024-12-310001506929us-gaap:OperatingSegmentsMember2025-10-012025-12-310001506929us-gaap:OperatingSegmentsMember2024-07-012024-12-310001506929us-gaap:OperatingSegmentsMember2025-07-012025-12-310001506929us-gaap:OperatingSegmentsMembervrdr:UnitedStatesAmericaRegionMember2024-10-012024-12-310001506929us-gaap:OperatingSegmentsMembervrdr:UnitedStatesAmericaRegionMember2025-10-012025-12-310001506929us-gaap:OperatingSegmentsMembervrdr:UnitedStatesAmericaRegionMember2024-07-012024-12-310001506929us-gaap:OperatingSegmentsMembervrdr:UnitedStatesAmericaRegionMember2025-07-012025-12-310001506929us-gaap:OperatingSegmentsMembervrdr:MalaysiaRegionMember2025-07-012025-12-310001506929us-gaap:OperatingSegmentsMembervrdr:MalaysiaRegionMember2025-10-012025-12-310001506929us-gaap:OperatingSegmentsMembervrdr:MalaysiaRegionMember2024-07-012024-12-310001506929us-gaap:OperatingSegmentsMembervrdr:MalaysiaRegionMember2024-10-012024-12-310001506929vrdr:ConsolidatedMember2025-12-310001506929vrdr:ConsolidatedMember2024-12-310001506929vrdr:ConsolidatedMember2024-07-012024-12-310001506929vrdr:ConsolidatedMember2025-07-012025-12-310001506929vrdr:ConsolidatedMember2024-10-012024-12-310001506929vrdr:ConsolidatedMember2025-10-012025-12-310001506929vrdr:CorporateUnallocatedMember2025-12-310001506929vrdr:CorporateUnallocatedMember2024-12-310001506929vrdr:CorporateUnallocatedMember2024-07-012024-12-310001506929vrdr:CorporateUnallocatedMember2025-10-012025-12-310001506929vrdr:CorporateUnallocatedMember2024-10-012024-12-310001506929vrdr:CorporateUnallocatedMember2025-07-012025-12-310001506929vrdr:LicensorofproprietarypyrolysistechnologyMember2025-12-310001506929vrdr:LicensorofproprietarypyrolysistechnologyMember2024-12-310001506929vrdr:LicensorofproprietarypyrolysistechnologyMember2024-07-012024-12-310001506929vrdr:LicensorofproprietarypyrolysistechnologyMember2025-10-012025-12-310001506929vrdr:LicensorofproprietarypyrolysistechnologyMember2024-10-012024-12-310001506929vrdr:LicensorofproprietarypyrolysistechnologyMember2025-07-012025-12-310001506929vrdr:HoldingPropertyMember2025-12-310001506929vrdr:HoldingPropertyMember2024-12-310001506929vrdr:HoldingPropertyMember2024-07-012024-12-310001506929vrdr:HoldingPropertyMember2025-10-012025-12-310001506929vrdr:HoldingPropertyMember2024-10-012024-12-310001506929vrdr:HoldingPropertyMember2025-07-012025-12-310001506929vrdr:ProductionAndDistributionOfRenewableCommoditiesMember2025-12-310001506929vrdr:ProductionAndDistributionOfRenewableCommoditiesMember2024-12-310001506929vrdr:ProductionAndDistributionOfRenewableCommoditiesMember2024-10-012024-12-310001506929vrdr:ProductionAndDistributionOfRenewableCommoditiesMember2025-07-012025-12-310001506929vrdr:ProductionAndDistributionOfRenewableCommoditiesMember2025-10-012025-12-310001506929vrdr:ProductionAndDistributionOfRenewableCommoditiesMember2024-07-012024-12-310001506929srt:DirectorMember2024-10-012024-12-310001506929srt:DirectorMember2025-10-012025-12-310001506929vrdr:EmployeesMember2024-10-012024-12-310001506929vrdr:EmployeesMember2025-10-012025-12-310001506929vrdr:NonEmployeesMember2024-10-012024-12-310001506929vrdr:NonEmployeesMember2025-10-012025-12-310001506929srt:DirectorMember2025-07-012025-12-310001506929vrdr:EmployeesMember2025-07-012025-12-310001506929vrdr:NonEmployeesMember2025-07-012025-12-310001506929srt:DirectorMember2024-07-012024-12-310001506929vrdr:EmployeesMember2024-07-012024-12-310001506929vrdr:NonEmployeesMember2024-07-012024-12-3100015069292024-07-012025-06-300001506929us-gaap:PropertyPlantAndEquipmentMember2025-07-012025-12-310001506929us-gaap:PropertyPlantAndEquipmentMember2024-07-012025-06-300001506929us-gaap:OfficeEquipmentMember2025-07-012025-12-310001506929vrdr:PlantAndMachineryMembervrdr:BottomMember2025-07-012025-12-310001506929vrdr:PlantAndMachineryMembervrdr:TopMember2025-07-012025-12-310001506929us-gaap:ComputerEquipmentMember2025-07-012025-12-310001506929vrdr:MotorVehiclesMember2025-07-012025-12-310001506929vrdr:FurnitureAndFittingsMember2025-07-012025-12-310001506929vrdr:RenovationMember2025-07-012025-12-310001506929vrdr:ErgonMember2025-10-080001506929vrdr:ErgonMember2025-10-012025-10-080001506929vrdr:ErgonMemberus-gaap:PrivatePlacementMember2025-12-310001506929vrdr:ErgonMemberus-gaap:PrivatePlacementMember2025-10-310001506929vrdr:ErgonMemberus-gaap:PrivatePlacementMember2025-10-012025-10-310001506929vrdr:VerdePlusIncVerdePlusOneMember2025-07-012025-12-310001506929vrdr:VerdeEstatesLLCMember2025-07-012025-12-310001506929vrdr:TheWisionProjectSdnBhdMember2025-07-012025-12-310001506929vrdr:VerdeLifeIncMember2025-07-012025-12-310001506929vrdr:VerdeRenewablesIncMember2025-07-012025-12-310001506929vrdr:VerdeResourcesMember2025-07-012025-12-310001506929vrdr:VerdeResourcesAsiaPacificimitedMember2025-07-012025-12-310001506929us-gaap:NoncontrollingInterestMember2025-12-310001506929vrdr:AccumulatedLossesMember2025-12-310001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001506929us-gaap:AdditionalPaidInCapitalMember2025-12-310001506929us-gaap:CommonStockMember2025-12-310001506929us-gaap:NoncontrollingInterestMember2025-10-012025-12-310001506929vrdr:AccumulatedLossesMember2025-10-012025-12-310001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-012025-12-310001506929us-gaap:AdditionalPaidInCapitalMember2025-10-012025-12-310001506929us-gaap:CommonStockMember2025-10-012025-12-3100015069292025-09-300001506929us-gaap:NoncontrollingInterestMember2025-09-300001506929vrdr:AccumulatedLossesMember2025-09-300001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001506929us-gaap:AdditionalPaidInCapitalMember2025-09-300001506929us-gaap:CommonStockMember2025-09-3000015069292025-07-012025-09-300001506929us-gaap:NoncontrollingInterestMember2025-07-012025-09-300001506929vrdr:AccumulatedLossesMember2025-07-012025-09-300001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001506929us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001506929us-gaap:CommonStockMember2025-07-012025-09-300001506929us-gaap:NoncontrollingInterestMember2025-06-300001506929vrdr:AccumulatedLossesMember2025-06-300001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001506929us-gaap:AdditionalPaidInCapitalMember2025-06-300001506929us-gaap:CommonStockMember2025-06-300001506929us-gaap:NoncontrollingInterestMember2024-12-310001506929vrdr:AccumulatedLossesMember2024-12-310001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001506929us-gaap:AdditionalPaidInCapitalMember2024-12-310001506929us-gaap:CommonStockMember2024-12-310001506929us-gaap:NoncontrollingInterestMember2024-10-012024-12-310001506929vrdr:AccumulatedLossesMember2024-10-012024-12-310001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001506929us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310001506929us-gaap:CommonStockMember2024-10-012024-12-3100015069292024-09-300001506929us-gaap:NoncontrollingInterestMember2024-09-300001506929vrdr:AccumulatedLossesMember2024-09-300001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001506929us-gaap:AdditionalPaidInCapitalMember2024-09-300001506929us-gaap:CommonStockMember2024-09-3000015069292024-07-012024-09-300001506929us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001506929vrdr:AccumulatedLossesMember2024-07-012024-09-300001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001506929us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001506929us-gaap:CommonStockMember2024-07-012024-09-300001506929us-gaap:NoncontrollingInterestMember2024-06-300001506929vrdr:AccumulatedLossesMember2024-06-300001506929us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001506929us-gaap:AdditionalPaidInCapitalMember2024-06-300001506929us-gaap:CommonStockMember2024-06-3000015069292024-12-3100015069292024-06-3000015069292024-07-012024-12-3100015069292024-10-012024-12-3100015069292025-10-012025-12-3100015069292025-06-3000015069292025-12-3100015069292026-02-13iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2025

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to _________

Commission file number: 000-55276

Verde Resources, Inc.

(Exact name of registrant as specified in its charter)

Nevada

32-0457838

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

8112 Maryland Ave, Suite 400

St. Louis, MO

63105

(Address of principal executive offices)

(Zip Code)

(314) 530-9071

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class:		Trading Symbol(s)		Name of Each Exchange on Which Registered
None		None		None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes ☒ No

As of February 13, 2026, there were 1,298,801,621 shares of common stock outstanding.

VERDE RESOURCES, INC.

TABLE OF CONTENTS

		Page
	Cautionary Note Regarding Forward-Looking Statements	iii
	Key Definitions	iii

	PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements	F-1
	Unaudited Condensed Consolidated Balance Sheets as of December 31, 2025 and June 30, 2025 (audited)	F-1
	Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended December 31, 2025 and 2024	F-2
	Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2025 and 2024	F-3
	Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended December 31, 2025 and 2024	F-4
	Notes to Unaudited Condensed Consolidated Financial Statements	F-6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	10
Item 4.	Controls and Procedures	10

	PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	11
Item 1A.	Risk Factors	11
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	11
Item 3.	Defaults upon Senior Securities	11
Item 4.	Mine and Safety Disclosure	11
Item 5.	Other Information	11
Item 6.	Exhibits	12

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (the “Quarterly Report”), and any documents we incorporate by reference, contain, or may contain, certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable rules and regulations. Such forward-looking statements involve significant risks and uncertainties. All statements contained in this Quarterly Report and any documents we incorporate by reference, other than statements of historical facts, are forward-looking statements including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

The words “may,” “will,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “potential,” “seek,” “goal” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements include statements regarding, and important factors that could cause actual outcomes to differ materially from those stated or implied in the forward-looking statements include, but are not limited to, the matters summarized below:

	·	our ability to establish and implement our business plan and begin to generate revenues, including through our licensing model strategy in conjunction with key commercial partners like Ergon Asphalt & Emulsions, Inc. (“Ergon”);

	·	our expectations about the anticipated benefits of licensing and distribution model strategy and our relationship with Ergon;

	·	the expected benefits of our proprietary road construction materials, including the cold mix biochar asphalt emulsifying agent we have licensed to Ergon for use in its products in North America;

	·	our ability to generate and monetize carbon renewal credits utilizing our technology and products;

	·	our ability to effectively compete in our industry and execute on our business plan;

	·	the impact of governmental laws and regulation, and our ability to comply with new regulations and compliance requirements that affect our business;

	·	our ability to effectively scale our operations in North America and other regions, either on our own or through third-party collaborators like Ergon and others;

	·	our ability to adequately market our products and services, and to develop additional products and product offerings;

	·	our ability to successfully expand our operations into foreign markets;

	·	assumptions related to the size of the market for our products and solutions;

	·	our future capital needs and our ability to raise additional capital;

	·	our ability to expand our licensing and distribution model to third parties beyond Ergon;

	·	our ability to expand our revenue streams beyond our licensing and distribution model;

	·	difficulties with certain licensees (such as Ergon), licensors from whom we have the rights to key intellectual property, or other third parties upon which we rely;

	·	our ability to attract, develop, and retain capable key personnel;

	·	our ability to protect our intellectual property (including our trade secrets) or manage threats posed by breaches of security; and

	·	other risks and uncertainties, including those listed in the “Risk Factors” section of this Quarterly Report, and our Annual Report on Form 10-K for the fiscal year ended June 30, 2025, filed with the Securities and Exchange Commission (“SEC”) on October 23, 2025.

These and other forward-looking statements are only predictions and we may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, so you should not place undue reliance on our forward-looking statements, which speak only as of the date of this Quarterly Report or, in the case of exhibits hereto, the date of those documents. In addition, the factors listed above may not be the only ones that impact our ability to achieve the results anticipated by our forward-looking statements. Actual results or events could differ materially and adversely from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. You are cautioned that forward-looking statements involve significant risks and uncertainties that are subject to change based on various factors (many of which are beyond our control). We have included important factors in the cautionary statements included in this Quarterly Report that could cause actual future results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.

You should read this Quarterly Report and the documents that we incorporate by reference with the understanding that our actual future results may be materially different from what we expect. All subsequent written or oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect events or circumstances after the date of this Quarterly Report or to reflect the occurrence of unanticipated events, except as may be required under applicable U.S. securities law. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

KEY DEFINITIONS

Unless the context requires otherwise, references in this Quarterly Report to “we,” “us,” “our,” “the Company,” “Verde,” or similar terminology refer to Verde Resources, Inc. and its consolidated subsidiaries

Unless the context requires otherwise, references in this Quarterly Report to “common stock” refer to the Company’s common stock, par value $0.001 per share.

iii

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1 - Financial Statements

VERDE RESOURCES, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

	December 31, 2025			June 30, 2025
ASSETS				Audited
Current assets:
Cash and cash equivalents	$	2,025,854		$	1,021,112
Deposit with banks		1,000,000			1,276,484
Accounts receivables		5,053			188,415
Inventories		286,707			284,561
Amount due from related party		-			100
Prepaid share-based compensation-nonemployees		45,415			455,291
Prepayments		109,140			46,605
Other receivables and deposits		9,666			15,647
		3,481,835			3,288,215

Assets held for sale		4,000			4,000

Total current assets		3,485,835			3,292,215

Non-current assets:
Property, plant and equipment, net		1,529,833			1,574,984
Right of use assets, net		444,262			518,375
Intangible assets		33,651,191			33,503,771
Security deposit		80,000			80,000
Prepaid share-based compensation- nonemployees		118,898			126,047

Total non-current assets		35,824,184			35,803,177

TOTAL ASSETS	$	39,310,019		$	39,095,392

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	54,216		$	55,092
Other payables		439,410			545,963
Deposit and accrued liabilities		49,377			371,837
Accrued share-based compensation for nonemployee		134,246			44,288
Accrued share-based compensation for employee		130,300			44,877
Current portion of operating lease liabilities		41,032			38,311
Amount due to a director		4,302			209,640
Amounts due to related parties		326,115			324,974

Total current liabilities		1,178,998			1,634,982

Non-current liabilities:
Operating lease liabilities, net of current portion		71,209			91,639

Total non-current liabilities		71,209			91,639

TOTAL LIABILITIES		1,250,207			1,726,621

Commitments and contingencies		-			-

STOCKHOLDERS’ EQUITY
Preferred stock, $0.001 par value, 50,000,000 shares authorized, none issued and outstanding		-			-
Common stock, $0.001 par value; 10,000,000,000 shares authorized; 1,294,224,767 and 1,262,680,891 issued and outstanding as of December 31, 2025 and June 30, 2025		1,294,224			1,262,680
Additional paid-in capital		57,090,906			54,530,117
Accumulated other comprehensive loss		(208,470	)		(160,809	)
Accumulated deficit		(20,114,112	)		(18,263,181	)
		38,062,548			37,368,807
Non-controlling interest		(2,736	)		(36	)
Stockholders’ equity		38,059,812			37,368,771

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	39,310,019		$	39,095,392

See accompanying notes to unaudited condensed consolidated financial statements.

F-1

Table of Contents

VERDE RESOURCES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME

(Currency expressed in United States Dollars (“US$”), except for number of shares)

	Three Months ended December 31,						Six Months ended December 31,
	2025			2024			2025			2024

Revenue, net	$	4,679		$	2,423		$	6,948		$	127,993

Cost of revenue		(886	)		(9,552	)		(2,221	)		(59,148	)

Gross profit (loss)		3,793			(7,129	)		4,727			68,845

Operating expenses:
Selling, general and administrative expenses		(1,126,428	)		(2,383,949	)		(2,015,404	)		(3,198,878	)
Other operating expenses		(57,241	)		(50,698	)		(113,137	)		(105,816	)
Total operating expenses		(1,183,669	)		(2,434,647	)		(2,128,541	)		(3,304,694	)

LOSS FROM OPERATION		(1,179,876	)		(2,441,776	)		(2,123,814	)		(3,235,849	)

Other income (expense):
Interest expense		-			(5,895	)		-			(101,360	)
Rental income		-			18,204			-			34,100
Gain from insurance claims		-			-			-			481,513
Unrealized foreign exchange gain (loss)		234,395			(442,021	)		251,734			276,680
Gain on disposal of property, plant and equipment		-			161,156			-			161,156
Interest income		4,779			16,272			11,823			38,809
Other income (expense)		6,626			(269	)		6,626			5,337
Total other income (expense), net		245,800			(252,553	)		270,183			896,235

LOSS BEFORE INCOME TAXES		(934,076	)		(2,694,329	)		(1,853,631	)		(2,339,614	)

Income tax expense		-			-			-			-

NET LOSS		(934,076	)		(2,694,329	)		(1,853,631	)		(2,339,614	)

Net loss attributable to non-controlling interest		(2,700	)		(27	)		(2,700	)		(27	)
Net loss attributable to Verde Resources Inc., shareholders		(931,376	)		(2,694,302	)		(1,850,931	)		(2,339,587	)

	$	(934,076	)	$	(2,694,329	)	$	(1,853,631	)	$	(2,339,614	)

Other comprehensive (loss) income :
– Foreign currency adjustment (loss) income		(29,002	)		57,161			(47,661	)		(39,022	)

COMPREHENSIVE LOSS	$	(963,078	)	$	(2,637,168	)	$	(1,901,292	)	$	(2,378,636	)

Net loss per share
– Basic	$	0.00		$	0.00		$	0.00		$	0.00
– Diluted	$	0.00		$	0.00		$	0.00		$	0.00

Weighted average common shares outstanding (restated)
– Basic		1,282,721,100			1,237,746,936			1,271,187,386			1,228,662,486
– Diluted		1,282,721,100			1,237,746,936			1,271,187,386			1,228,662,486

See accompanying notes to unaudited condensed consolidated financial statements.

F-2

Table of Contents

VERDE RESOURCES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Currency expressed in United States Dollars (“US$”))

	Six Months ended December 31,
	2025			2024
				Re-presented
Cash flows from operating activities:
Net loss	$	(1,853,631	)	$	(2,339,614	)

Adjustments to reconcile net loss to net cash used in by operating activities
Depreciation of property, plant and equipment		111,676			137,375
Amortization		51,429			51,429
Stock-based compensation-nonemployee		601,983			545,859
Stock-based compensation-employee		118,065			201,680
Stock-based compensation-director		16,691			-
Finance cost interest element of promissory notes (non-cash)		-			84,718
Operating lease expense		28,407			14,120
Impairment on property		-			137,632
Unrealized foreign exchange gain		(251,734	)		(276,680	)
Gain from insurance claim		-			(481,513	)
Loss from disposal of asset held for sale		-			2,876
Gain on disposal of property, plant and equipment		-			(161,156	)
Changes in operating assets and liabilities:
Accounts receivable		183,423			(121,411	)
Other receivables and deposits		6,458			(34,940	)
Prepayments		(62,535	)		(14,221	)
Inventories		1,300			40,741
Accounts payables		(2,999	)		10,933
Accrued liabilities and other payables		(438,496	)		19,503
Advanced from director		(205,076	)		1,279,047
Advanced from/to related parties		1,025			(90,658	)
Repayment of operating lease liabilities		(23,189	)		(14,120	)
Net cash used in operating activities		(1,717,203	)		(1,008,400	)

Cash flows from investing activities:
Proceeds from disposal of assets held for sale		-			593,300
Proceeds from insurance recoveries		-			541,221
Withdrawal of deposit with bank, net		276,484			250,000
Purchase of property, plant and equipment		-			(358	)
Net cash provided by investing activities		276,484			1,384,163

Cash flows from financing activities:
Repayments to lease liabilities		-			(614,474	)
Proceeds from issuance of common stock and Common Stock to be issued		2,448,000			904,000
Cash outflow arising from cancellation of Common Stock		-			(45,000	)
Net cash provided by financing activities		2,448,000			244,526

Net change in cash and cash equivalents		1,007,281			620,289

Foreign currency translation adjustment		(2,539	)		(7,426	)

Net change in cash and cash equivalents		1,004,742			612,863

CASH AND CASH EQUIVALENTS, AT BEGINNING OF PERIOD		1,021,112			279,137

CASH AND CASH EQUIVALENTS, AT END OF PERIOD	$	2,025,854		$	892,000

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes	$	-		$	-
Cash paid for interest	$	-		$	9,223

SUPPLEMENTAL NONCASH DISCLOSURE:
Cash paid for income taxes	$	-	$	-
Shares issuance for employee compensation	$	-	$	198,629

See accompanying notes to unaudited condensed consolidated financial statements.

F-3

Table of Contents

VERDE RESOURCES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED DECEMBER 31, 2025 AND 2024

(Currency expressed in United States Dollars (“US$”), except for number of shares)

	Common stock				Additional		Accumulated other						Non			Total
	No. of shares		Amount		paid-in capital		comprehensive loss			Accumulated losses			controlling interest			stockholders’ equity

Balance as of July 1, 2025		1,262,680,891	$	1,262,680	$	54,530,117	$	(160,809	)	$	(18,263,181	)	$	(36	)	$	37,368,771

Shares issued for private placement		5,600,000		5,600		442,400		-			-			-			448,000
Share based compensation to employee, vested portion		-		-		32,642		-			-			-			32,642
Share based compensation to director, vested portion		-		-		8,345		-			-			-			8,345
Shares issued to service provider		1,000,000		1,000		94,000		-			-			-			95,000
Net loss for the period		-		-		-		-			(919,555	)		-			(919,555	)
Foreign currency translation adjustment		-		-		-		(18,659	)		-			-			(18,659	)

Balance as of September 30, 2025		1,269,280,891	$	1,269,280	$	55,107,504		(179,468	)	$	(19,182,736	)	$	(36	)	$	37,014,544

Shares issued for private placement		24,943,876		24,944		1,975,056		-			-			-			2,000,000
Share based compensation to director, vested portion		-		-		8,346		-			-			-			8,346
Net loss for the period		-		-		-		-			(931,376	)		(2,700	)		(934,076	)
Foreign currency translation adjustment		-		-		-		(29,002	)		-			-			(29,002	)

Balance as of December 31, 2025		1,294,224,767	$	1,294,224	$	57,090,906		(208,470	)	$	(20,114,112	)	$	(2,736	)	$	38,059,812

See accompanying notes to unaudited condensed consolidated financial statements.

F-4

Table of Contents

VERDE RESOURCES, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED DECEMBER 31, 2025 AND 2024

(Re-presented)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

	Common stock						Additional			Accumulated other comprehensive						Non			Total
	No. of shares			Amount			paid-in capital			(loss) income			Accumulated losses			controlling interest			stockholders’ equity

Balance as of July 1, 2024		1,221,346,586		$	1,221,346		$	49,647,034		$	(71,906	)	$	(13,480,204	)	$	-		$	37,316,270

Shares issued for private placement		6,024,439			6,024			577,976			-			-			-			584,000
Shares issued to service provider		2,700,000			2,700			927,300			-			-			-			930,000
Shares issued to employee, vested portion		2,020,000			2,020			240,244			-			-			-			242,264
Shares issued as settlement of promissory notes		9,655,542			9,656			666,232			-			-			-			675,888
Net income for the period		-			-			-			-			354,715			-			354,715
Foreign currency translation adjustment		-			-			-			(96,183	)		-			-			(96,183	)

Balance as of September 30, 2024		1,241,746,567		$	1,241,746		$	52,058,786			(168,089	)	$	(13,125,489	)	$	-		$	40,006,954

Shares issued for private placement		3,277,775			3,278			316,722			-			-			-			320,000
Shares issued to service provider		4,656,550			4,656			740,392			-			-			-			745,048
Shares issued to employee, vested portion		50,000			50			3,001			-			-			-			3,051
Share based compensation to employee, vested portion		-			-			92,044			-			-			-			92,044
Shares cancelled		(450,000	)		(450	)		(44,550	)		-			-			-			(45,000	)
Net loss for the period		-			-			-			-			(2,694,302	)		(27	)		(2,694,329	)
Foreign currency translation adjustment		-			-			-			57,161			-			-			57,161

Balance as of December 31, 2024		1,249,280,892		$	1,249,280		$	53,166,395			(110,928	)	$	(15,819,791	)	$	(27	)	$	38,484,929

See accompanying notes to unaudited condensed consolidated financial statements.

F-5

Table of Contents

VERDE RESOURCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2025 AND 2024

(Currency expressed in United States Dollars (“US$”), except for number of shares)

NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND

Verde Resources, Inc. was incorporated under the laws of the state of Nevada on April 22, 2010.

The Company is a road construction and building materials company offering proprietary, environmentally sustainable materials, with the goal to drive innovations that enhance sustainability and advance environmental stewardship. By integrating biochar, a highly effective carbon sequester and performance enhancer, the Company intends to facilitate the industry’s transition to zero emissions. The Company believes its approach reduces greenhouse gas (“GHG”) emissions, optimizes the use of native soils and recycled materials, speeds installation, and improves efficiency while cutting costs. Since June 2023 the Company’s strategic focus has been on testing the Company’s biochar asphalt technology through the Company’s subsidiary, Verde Renewables Inc. (“Verde Renewables”), at the National Center for Asphalt Technology (“NCAT”) test track. This endeavor with NCAT is rigorously testing the Company’s innovative biochar asphalt technology, which is intended to provide superior performance, environmental sustainability, and the generation of carbon removal and avoidance credits.

In December 2024, in collaboration with C-Twelve Pty Ltd, a corporation incorporated in Western Australia (“C-Twelve”), we successfully demonstrated our pioneering biochar-asphalt technology at the NCAT test track in Auburn, Alabama. The project showcased the ability to retrofit an existing asphalt plant to produce cold-mix biochar asphalt under winter conditions without the use of heat, solvents, or odors, resulting in an estimated 50% increase in installation efficiency compared to conventional methods.

The demonstration sequestered approximately eight (8) tons of carbon, verified and certified under Puro.earth in collaboration with Oregon Biochar Solutions, a related party of the Company through Karl Strahl, Chief Operating Officer of Oregon Biochar Solutions, who was appointed as a director of the Company in May 2025. This achievement marked what the Company believes to be the world’s first carbon removal credits generated through asphalt production and installation. The credits, issued and sold in April 2025, were pre-purchased by one of the world’s largest financial institutions focused on Carbon Dioxide Removals (CDRs). The Company refers to this integrated model of combining low-carbon materials, operational efficiency, and verified carbon removal credit generation as the “Verde Net Zero Blueprint.”

In July 2025 the Company received early validation based on performance results from NCAT which demonstrated consistent durability, particularly under low-volume roadway conditions. Further in September 2025, NCAT’s latest evaluation of Verde’s cold recycling mix using 100% reclaimed asphalt pavement (“RAP”) from laboratory testing demonstrated that Verde’s cold-recycled mix not only meets but exceeds industry specifications for cold-recycled asphalt. Results showed superior cohesion, high tensile strength ratio (“TSR”), and retained stability compared to standard cold mix benchmarks, validating its strength, durability, and moisture resistance.

Puro.earth, the crediting platform for durable carbon removal, has officially registered the Company as a Carbon Removal Credit supplier as part of its Accelerate program. This registration was formalized through a platform agreement signed in April 2023. The Company’s endeavors are positioned to potentially create additional revenue opportunities through the generation of carbon removal credits (“CORCs”). The Company believes that the generation of CORCs and the demand for CORCs incentivizes the broader adoption of climate technologies and enables the Company to supply these credits to companies seeking to offset their carbon footprint in pursuit of net-zero objectives. Simultaneously, this approach creates the potential for an additional and substantial revenue stream for the Company.

The Company’s current priority is the successful commercialization of its technology in North America, and if that commercialization is successful, the Company intends to introduce the same blueprint in Malaysia. Ongoing discussions with PLUS Malaysia, the country’s largest highway operator, signal a growing demand for biochar in the region. This demand, coupled with the certification, could enable the BioFraction™ plant to secure a reliable client, ensuring the resumption of normal operations in Malaysia with the potential for significant scale-up over time.

During the period ended December 31, 2025 and year ended June 30, 2025, the Company achieved the following major milestones on its path to commercialization of its biochar-asphalt technology and achieving “net-zero”:

On June 27, 2024, the Company entered into an agreement with NCAT at Auburn University to undertake a 3-year Performance Testing Project titled “Structural Capacity of Sustainable Pavement” (the “Project”). The Project, led by Dr. Nam Tran, Associate Director and Research Professor at NCAT, involved a comprehensive performance testing on the NCAT Test Track in Opelika, Alabama. This facility, sponsored by various state Departments of Transportation (DOTs) and in partnership with the Minnesota Road Research Facility (MnROAD), is dedicated to advancing sustainable pavement technologies. Success in this Project is expected to drive widespread adoption of a net-zero road construction blueprint by DOTs across the United States and the federal DOT. The Project commenced on June 24, 2024, and is expected to conclude on September 30, 2027, with the first draft of the final report expected in Spring 2027.

In July 2025, the Company received encouraging preliminary performance results from NCAT regarding its Cold-Mix Biochar-Asphalt test section at NCAT’s Test Track installed in December 2024. After approximately 50,000 equivalent single axle loads (ESALs) of heavy truck traffic, the asphalt surface remained flexible and demonstrated consistent durability, particularly under low-volume roadway conditions, as confirmed by NCAT's Assistant Director for Test Track Research, Mr. Nathan Moore. This demonstration marks the world’s first deployment of a carbon‑sequestering asphalt material engineered to maintain competitive strength and flexibility for road applications. Verde announced this milestone in a press release on July 28, 2025.

F-6

Table of Contents

Further, in September 2025, NCAT’s latest evaluation of Verde’s cold recycling mix using 100% reclaimed asphalt pavement (“RAP”) further validated the testing results of our proprietary formulation. Laboratory testing conducted in accordance with ASTM D6927 (Marshall Stability and Flow), ASTM D6931 (Indirect Tensile Strength), and AASHTO T283 (Moisture Susceptibility) demonstrated that Verde’s cold-recycled mix not only meets but exceeds industry specifications for cold-recycled asphalt. Results showed superior cohesion, high tensile strength ratio (“TSR”), and retained stability compared to standard cold mix benchmarks, validating its strength, durability, and moisture resistance.

On August 14, 2024, the Company entered into a Memorandum of Understanding (the “NPI MOU”) with Nature Plus Inc. (“NPI”) to formalize the collaboration on the NCAT Project referred to above and explore subsequent business opportunities arising from the successful completion of the Project. The Project involved the application of TerraZyme technology for the stability of subgrade and base layers, with the overarching goal of advancing road construction methodologies. The testing of the efficacy and exploration of potential applications of the TerraZyme technology at NCAT is still underway as of the date of this Quarterly Report.

Under the NPI MOU, the Company and NPI agreed to jointly develop mixed designs and materials incorporating biochar, aimed at enhancing performance and promoting carbon sequestration. The NPI MOU shall be effective until December 31, 2026, or until replaced by a subsequent distributor agreement. Upon the completion of the Project, if successful, the Company and NPI intend to continue the collaboration on future initiatives, including soil stabilization and material development, carbon removal credits, certification and compliance, and exclusive rights to distributing TerraZyme.

On October 16, 2024, the Company formed a new subsidiary, VerdePlus Inc. (“VerdePlus”), a Missouri corporation in partnership with NPI for the purpose of conducting business on the production of low-carbon building materials by integrating the Company’s expertise and the innovative intellectual property of NPI. The Company and NPI owned 55% and 45% of VerdePlus, respectively.

On October 18, 2024, the Company entered into a binding Term Sheet with C-Twelve granting the Company (i) an exclusive license to utilize its proprietary binder and biochar asphalt mixed designs (the “Licensed Technology”) for the production and commercialization of asphalt surfacing-related products (the “End Products”) within the United States of America and (ii) the first right of refusal to extend the exclusive licensing of the Licensed Technology to other countries and territories subject to terms and conditions to be mutually agreed upon. Subsequently on May 19, 2025, the Company and C-Twelve entered into a definitive agreement, namely the Joint Development Agreement (“C-Twelve Agreement”) which provides for a 10 year license commencing May 19, 2025.

Effective October 8, 2025, the Company entered into an addendum to the C-Twelve Agreement (the “C-Twelve Addendum”) with C-Twelve pursuant to which (i) C-Twelve approved the Company’s entry into the License Agreement with Ergon (as described below), (ii) the exclusive territory granted to the Company under the C-Twelve Agreement is expanded to comprise the United States (including all states, territories, and regions thereof), Canada and Mexico, (iii) the Company agreed to pay an additional $1 million in exclusive licensing fees for the expanded territories of Canada and Mexico, which shall be paid concurrently with the $2 million loan previously agreed upon under the C-Twelve Agreement (the “C-Twelve Loan”) and (iv) the Company agreed to a potential conditional fee payment to C-Twelve in 2027 based on agreed minimum amounts of liters of Verde V24 which the Company may purchase from C-Twelve. The Company is required to fund the C-Twelve Loan and the additional $1 million fee to C-Twelve (the proceeds of which are expected to be used by C-Twelve in part to enhance its Verde V24 manufacturing capability) within thirty (30) days of closing of a transaction in which the Company’s common stock becomes listed on a U.S. national exchange, provided that if such funding is not achieved by July 31, 2026, C-Twelve shall have the right, on ten (10) business days’ notice, to hold the Company in breach of the C-Twelve Agreement.

Ergon License

On October 10, 2025, Verde Renewables entered into a license agreement with Ergon (the “Ergon License”), pursuant to which the Company has granted Ergon an exclusive, non-transferable license to use, manufacture, commercialize, market, sell and distribute any product that contains or is manufactured or formed by Ergon using the Company’s proprietary cold mix biochar asphalt emulsifying agent, Verde V24, in the United States (including its territories), Canada and Mexico, in exchange for Ergon agreeing to purchase Verde V24 from the Company at a fixed price (which is inclusive of all fees associated with the license, but subject to consumer price index adjustments) for use in Ergon’s asphalt road materials products.

The Company has agreed with Ergon to an initial fifteen (15) month “go-to-market period”, during which there will be no minimum purchase requirements for Ergon’s purchases of Verde V24. For each calendar year beginning January 1, 2027, Ergon has agreed to negotiate with the Company in good faith towards the establishment of possible minimum purchase amounts based on certain customary factors. The Company has also agreed with Ergon that if minimum purchase amounts are agreed to for any given calendar year, the Company and Ergon will agree in good faith to new minimum purchase amounts for each subsequent year, subject to consideration of customary factors.

The Company has also agreed to provide Ergon with forty percent (40%) of its share of the carbon removal credits generated from the mixing of the final carbon sequestering BioAsphalt™ surface material, so long as:

(a) the carbon removal credits are generated from bulk mixing or packaged mixed product, and

(b) the mixing of the final BioAsphalt™ surface material includes biochar purchased from the Company.

The Ergon License additionally grants Ergon the right to use the Company’s trademarks and access to ongoing technical services to facilitate the monitoring, reporting, and verification process of each ton of carbon dioxide sequestered.

The term of the Ergon License is ten (10) years, with an automatic renewal for additional ten (10) year periods, subject to a minimum of six (6) months’ notice of cancellation prior to renewal. The Ergon License may be terminated in the event of non-payment of amounts due, initiation of bankruptcy proceedings, or under other customary terms. Additionally, Ergon may terminate the Ergon License upon sixty (60) days’ prior written notice in the event that our Chief Executive Officer, Jack Wong, or our Chief Operating Officer, Eric Bava, are removed from their respective positions with the Company for reasons other than termination for cause or voluntary resignation.

F-7

Table of Contents

Ergon Private Placement

On October 31, 2025, the Company entered into a securities purchase agreement (the “Ergon Purchase Agreement”) with Ergon, pursuant to which Ergon purchased a total of 24,943,876 unregistered shares (the “Ergon Shares”) of the Company’s common stock and an unregistered warrant (the “Warrant”) to purchase 24,943,876 shares of common stock (the “Warrant Shares”), at a combined purchase price of $0.08018 per share (the “Offering Price”), which represents a five percent (5%) discount to the volume-weighted average price of the Company’s common stock for the thirty (30) trading days immediately preceding the closing of the offering of the Ergon Shares and Warrant by the Company to Ergon (the “Offering”).

The Company received gross proceeds of $2 million from the Offering, excluding proceeds, if any, from the exercise of the Warrant. The Company intends to use the proceeds of the Offering for working capital and general corporate purposes.

Under the terms of the Ergon Purchase Agreement, Ergon is prohibited from selling any shares of common stock acquired in the Offering without the Company’s prior written consent until 180 days (the “Standstill Period”) after the closing of a firm commitment public offering of the common Stock and concurrent uplisting to a national market exchange by the Company (the “Uplist”); provided that if the Uplist has not occurred by September 30, 2026, the prohibition on sales will terminate. The Ergon Purchase Agreement additionally grants Ergon (i) the right to appoint a non-voting observer to the Company’s board of directors for so long as Ergon holds one third (1/3) of the shares of common stock acquired in the Offering and so long as the Ergon License has not expired or been terminated in accordance with its terms, (ii) certain “piggyback” registration rights, whereby, subject to certain exceptions, following the Standstill Period, if the Company files a registration statement for the public offer and sale of its securities, Ergon has the right to have the Ergon Shares and Warrant Shares included in such registration statement for public resale, and (iii) subject to customary exemptions, a three (3) year right of participation in any issuance by the Company of common stock or Common Stock Equivalents (as defined in the Ergon Purchase Agreement) in a Company financing transaction, whereby Ergon has the right to participate in such transaction up to its then-current percentage holdings of the outstanding common stock as determined by dividing the number of shares of common stock then held by Ergon by the number of shares of common stock then outstanding.

Dissolution of BRL and Transfer of Intellectual Property

Pursuant to an Intellectual Property Transfer Agreement dated October 15, 2025, Bio Resources Limited (“BRL”), a wholly owned subsidiary of the Company, transferred to Verde Resources Asia Pacific Limited (“VRAP”), another wholly owned subsidiary of the Company, all rights, title and interest in the intellectual property known as Catalytic Biofraction Process at its carrying value of $30,192,771 as of that date. Following the completion of the transfer, BRL was administratively dissolved by being struck off the registers of the Labuan Financial Services Authority on October 19, 2025.

As of December 31, 2025, the Company has the following subsidiaries:-

Company name	Place of incorporation	Principal activities and place of operation	Effective interest held

Verde Resources Asia Pacific Limited (“VRAP”)	British Virgin Islands	Investment holding	100%

Verde Resources (Malaysia) Sdn Bhd (“Verde Malaysia”)	Malaysia	Manufacturing and distribution of renewable agricultural commodities, and provision of consultation services related thereto	100%

Verde Renewables, Inc.	State of Missouri	Trading of building materials and management of a processing and packaging facility	100%

VerdePlus Inc.	State of Missouri	Production of low-carbon building materials	55%

Verde Life Inc. (“VLI”)	State of Oregon	Development of health and wellness products formulated with natural plant extracts derived from crops cultivated using biochar.	100%

The Wision Project Sdn Bhd (“Wision”)	Malaysia	Digital innovation, marketing & consulting service, PR, branding, influencer marketing, event management and media relations services	100%

Verde Estates LLC (“VEL”)	State of Missouri	Holding real property	100%

* Bio Resources Limited (“BRL”), a former subsidiary of the Company, was administratively dissolved by being struck off the registers of the Labuan Financial Services Authority, effective October 19, 2025.

F-8

Table of Contents

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying unaudited condensed consolidated financial statements and notes.

·	Basis of Presentation

The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and those of its wholly owned subsidiaries and variable interest entities, are unaudited and have been prepared on a basis substantially consistent with the Company’s audited financial statements and notes as of and for the year ended June 30, 2025 included in the Company’s Annual Report on Form 10-K (the “2025 Form 10-K”). These unaudited condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted (“GAAP”) in the United States of America (“U.S. GAAP”) and follow the requirements of the SEC for interim reporting. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting only of adjustments of a normal and recurring nature) considered necessary for a fair statement of its financial position, operating results and cash flows for the periods presented. The condensed consolidated balance sheet at June 30, 2025 has been derived from audited consolidated financial statements, but does not contain all of the footnote disclosures from the 2025 Form 10-K. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. The statements should be read in conjunction with the audited consolidated financial statements and related notes included in the 2025 Form 10-K as filed with SEC on October 23, 2025.

·	Use of Estimates and Assumptions

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the years presented. Significant accounting estimates reflected in the Company’s condensed consolidated financial statements include the useful lives of plant and equipment, impairment of long-lived assets (including intangible assets), allowance for expected credit losses, revenue recognition, share based compensation, classification of warrants, deferred taxes and uncertain tax position.

The inputs into the management’s judgments and estimates consider the geopolitical tension, inflationary and high-interest rate environment and other macroeconomic factors on the Company’s critical and significant accounting estimates. Actual results could differ from these estimates.

·	Basis of Consolidation

The unaudited condensed consolidated financial statements include the financial statements of Verde Resources, Inc. and its subsidiaries. All significant inter-company balances and transactions within the Company and its subsidiaries have been eliminated upon consolidation. The Company accounts for acquisitions in accordance with guidance found in ASC 805, Business Combinations. The guidance requires consideration given, including contingent consideration, assets acquired, and liabilities assumed to be valued at their fair market values at the acquisition date.

·	Segment Reporting

Accounting Standard Codification (“ASC”) Topic 280, Segment Reporting establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company has three reportable business segments.

Sales and operating income as the primary measures of segment profit or loss to assess performance and make resource allocation decisions. The CODM assesses these metrics and compares actuals to budgeted and forecasted values to evaluate segment operating performance and allocate resources to the operating segments. Expenses related to certain centralized administration or executive functions that are not specifically related to an operating segment are included in Corporate Unallocated.

·	Concentration of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents, deposit with banks and accounts receivable. The Company places its cash and cash equivalents and bank deposits with financial institutions of high credit worthiness. At times, its cash and cash equivalents and bank deposits with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

F-9

Table of Contents

·	Risks and Uncertainties

The Company has a limited operating history in the supply of net zero road constructions and building materials. Therefore, the Company’s business is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with a production operation for renewable commodities, including the potential risk of business failure.

·	Cash and Cash Equivalents

Cash and cash equivalents are carried at cost and represent cash in banks, money market funds, which are readily convertible to known amounts of cash and that mature within three months or less from the date of purchase, which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $2,025,854 and $1,021,112 in cash and cash equivalents at December 31, 2025 and June 30, 2025.

At December 31, 2025, and June 30, 2025, cash and cash equivalents consisted of petty cash on hand and cash in banks.

·	Deposits with Banks

Deposits held for investments that are not debt securities are included in short-term investments in the unaudited condensed consolidated balance sheets. Investments in time deposits with original maturities of more than three months but remaining maturities of less than one year are considered short-term investments. Investments held with the intent to reinvest or hold for longer than a year, or with remaining maturities of one year or more, are considered long-term investments.

·	Accounts Receivables

Accounts receivables are recognized and carried at amortized cost. The Company maintains an allowance for expected credit loss to provide for the estimated number of receivables that will not be collected. The Company considers several factors in its estimate of the allowance, including knowledge of a client’s financial condition, its historical collection experience, and other factors relevant to assessing the collectability of such receivables. Bad debts are written off against allowances. An allowance for doubtful accounts will be recorded in the period when a loss is probable based on an assessment of specific evidence indicating troubled collection, historical experience, accounts aging, ongoing business relation and other factors. Accounts are written off after exhaustive efforts at collection. If accounts receivable are to be provided for, or written off, they would be recognized in the unaudited condensed consolidated statement of operations within operating expenses. As of December 31, 2025, and June 30, 2025, the longest credit term for certain customers are 30 to 90 days.

At December 31, 2025, and June 30, 2025, there has been no allowance for expected credit loss for accounts receivables, and for other receivables, the allowance for expected credit loss amounted to $0 and $33,939 respectively. There was no allowance for expected credit loss for the three and six months ended December 31, 2025 and 2024.

·	Expected Credit Loss

ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments requires entities to use a current lifetime expected credit loss methodology to measure impairments of certain financial assets. Using this methodology will result in earlier recognition of losses than under the previous incurred loss approach, which requires waiting to recognize a loss until it is probable of having been incurred. There are other provisions within the standard that affect how impairments of other financial assets may be recorded and presented, and that expand disclosures.

·	Inventories

Inventories are stated at the lower of cost or market value (net realizable value), with cost being determined on a first-in-first-out method. Cost of raw materials include cost of materials and incidental costs in bringing the inventory to its current location. Costs of finished goods, on the other hand include material, labor and overhead costs. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand.

As of December 31, 2025, and June 30, 2025, there was no write down and no write off of inventories.

F-10

Table of Contents

·	Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

		Expected useful life
Plant and machinery		5-10 years
Office equipment		3 years
Computers		5 years
Motor vehicles		5 years
Furniture and fittings		5 years
Renovation		10 years

Expenditures for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures for major renewals and betterment which substantially extend the useful life of assets are capitalized. The cost and related accumulated depreciation of assets retired or sold are removed from the respective accounts, and any gain or loss is recognized in the unaudited condensed consolidated statements of income and other comprehensive income in other income or expenses.

Depreciation expense for the three months ended December 31, 2025 and 2024, totaled $56,517 and $67,145, respectively.

Depreciation expense for the six months ended December 31, 2025 and 2024, were $111,676 and $137,375, respectively.

As of December 31, 2025, and June 30, 2025, the impairment loss on plant and machinery amounted to $0 and $137,632 respectively, and the Company did not record any write off of plant and machinery for the three and six months ended December 31, 2025 and 2024. There was no impairment loss on plant and equipment for the three and six months ended December 31, 2025. An impairment loss of $137,632 on plant and machinery was recognized for each of the three and six months ended December 31, 2024.

·	Intangible assets

Intangible assets acquired from third parties are measured initially at fair value and those with an infinite live are not amortized. The Company annually evaluates the recoverability of the infinite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. To test indefinite-lived intangible assets for impairment, the Company first performs a qualitative assessment to determine if it is more likely than not that the carrying amount of each of its indefinite-lived intangible assets exceeds its fair value. If it is, a quantitative assessment is required. Alternatively, the Company may bypass the qualitative assessment and perform a quantitative impairment test. The qualitative assessment requires the consideration of factors such as recent market transactions, macroeconomic conditions and changes in projected future cash flows. The quantitative assessment compares the fair value of an indefinite-lived intangible asset to its carrying amount. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized for the excess. Fair values of indefinite-lived intangible assets are determined based on discounted cash flows or appraised values, as appropriate. If such a review indicates that the carrying amount of intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value.

As of December 31, 2025, and June 30, 2025, the Company did not record an impairment on the intangible assets.

·	Assets held for sale

The Company classifies assets as held-for-sale (“disposal group”) in the period when all of the relevant criteria to be classified as held for sale are met. These criteria include management’s commitment to sell the disposal group in its present condition and the sale being deemed probable of being completed within one year. Assets held for sale are reported at the lower of their carrying value or fair value less cost to sell. The fair values of disposal groups are estimated using accepted valuation techniques, including indicative listing prices. The Company considers historical experience, guidance received from third parties, and all information available at the time the estimates are made to derive fair value. Any loss resulting from the measurement is recognized in the period when the held for sale criteria are met. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the initial carrying value of the disposal group. Assets held-for-sale are not amortized or depreciated.

·	Impairment of Long-lived Assets

In accordance with the provisions of ASC Topic 360, Impairment or Disposal of Long-Lived Assets, all long-lived assets such as property, plant and equipment owned and held by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets.

There was no impairment loss on plant and equipment for the three and six months ended December 31, 2025. An impairment loss of $137,632 on plant and machinery was recognized for each of the three and six months ended December 31, 2024.

F-11

Table of Contents

·	Revenue Recognition

ASC Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers.

The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfils its obligations under each of its agreements:

·	identify the contract with a customer;
·	identify the performance obligations in the contract;
·	determine the transaction price;
·	allocate the transaction price to performance obligations in the contract; and
·	recognize revenue as the performance obligation is satisfied.

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct. Accordingly, the transaction price is allocated in its entirety to the single performance obligation and recognized upon its fulfilment.

The Company considers customer order confirmations, whether formal or otherwise, to be a contract with the customer. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled.

The Company also follows the guidance provided in ASC 606, Revenue from Contracts with Customers, for determining whether the Company is the principal or an agent in arrangements with customers that involve another party that contributes to the provision of goods to a customer. In these instances, the Company determines whether it has promised to provide the goods itself (as principal) or to arrange for the specified goods to be provided by another party (as an agent). This determination is a matter of judgment that depends on the facts and circumstances of each arrangement. The Company derives its revenue from the sale of products and services in its role as a principal.

·	Rental income

Rental income is recognized on a straight-line basis over the term of the respective lease agreement.

·	Cost of revenue

Cost of revenue consists primarily of the cost of goods sold, which are directly attributable to the sales of products.

Leases

The Company determines if an arrangement is a lease or contains a lease at inception. Operating lease liabilities are recognized based on the present value of the remaining lease payments, discounted using the discount rate for the lease at the commencement date. The Company uses rate implicit in the lease to determine the present value of future lease payments to determine the present value of future lease payments. Operating lease right-of-use (“ROU assets”) assets represent the Company’s right to control the use of an identified asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are generally recognized based on the amount of the initial measurement of the lease liability. Lease expense is recognized on a straight-line basis over the lease term. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities.

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC Topic 360, Property, Plant, and Equipment, as ROU assets are long-lived non-financial assets.

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU assets are not independent from the cash flows of other assets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities.

The Company recognized no impairment of ROU assets as of December 31, 2025, and June 30, 2025.

The operating lease is included in operating lease right-of-use assets and operating lease liabilities as current and non-current liabilities in the unaudited condensed consolidated balance sheets as of December 31, 2025, and June 30, 2025.

F-12

Table of Contents

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the five criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value and (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to us, while the leased asset is depreciated in accordance with our depreciation policy if the title is to eventually transfer to us. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 842.

·	Income Taxes

The Company adopted the ASC Topic 740, Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the unaudited condensed consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the unaudited condensed consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

·	Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC Topic 740 provisions of Section 740-10-25 for the three and six months ended December 31, 2025 and 2024.

·	Foreign Currencies Translation

The Company’s reporting currency is the United States dollar (“US$”) and the accompanying unaudited condensed consolidated financial statements have been expressed in United States dollars. The Company and its subsidiaries in the United States have functional currency of US$ whereas the functional currency of the Company’s subsidiaries in Malaysia is Malaysian Ringgit (“MYR”). The functional currencies represent the primary currencies of the economic environment in which the respective companies’ operations are conducted.

Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the unaudited condensed consolidated statement of operations.

For reporting purposes, in accordance with ASC Topic 830 “Translation of Financial Statements”, capital accounts of the unaudited condensed consolidated financial statements are translated into United States dollars from MYR at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rates as of balance sheet date. Income and expenditures are translated at the average exchange rate of the respective year. The gains and losses resulting from translation of financial statements subsidiaries to the reporting currency are recorded as a separate component of accumulated other comprehensive income within the statements of changes in stockholder’s equity.

Translation of MYR into U.S. dollars has been made at the following exchange rates for the following periods:-

December 31,

2025

December 31,

2024

Period-end MYR:US$ exchange rate

0.24703

0.22369

Average period MYR:US$ exchange rate

0.23945

0.22809

·	Comprehensive Income

ASC Topic 220, Comprehensive Income, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying unaudited condensed consolidated statements of changes in stockholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

F-13

Table of Contents

·	Non-controlling Interest

The Company accounts for non-controlling interest in accordance with ASC Topic 810-10-45, which requires the Company to present non-controlling interests as a separate component of total shareholders’ equity on the unaudited condensed consolidated balance sheets and the unaudited condensed consolidated net loss attributable to the non-controlling interest be clearly identified and presented on the face of the unaudited condensed consolidated statements of operations and comprehensive loss.

·	Net Loss per Share

The Company calculates net loss per share in accordance with ASC Topic 260, Earnings per Share. Basic income per share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period. Non-vested share-based payment awards are excluded from the basic EPS calculation. Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued, including warrants and those granted but are non-vested and are non-forfeitable, and if the additional common shares were dilutive.

For the six months ended December 31, 2025 and 2024, diluted weighted-average common shares outstanding is equal to basic weighted average common shares, due to the Company’s net loss position. Hence no common stock equivalents were included in the computation of diluted net loss per shares since such inclusion would have been antidilutive.

·	Stock Cancellation and Reissuance Policy

The Company may cancel shares of its common stock that have been repurchased or otherwise reacquired, including shares acquired through share repurchase programs or forfeited under equity compensation plans. Canceled shares are retired and removed from the issued and outstanding share count in accordance with applicable corporate law and the Company’s Articles of Incorporation.

Upon cancellation, the par value of the shares is deducted from common stock, and any excess of repurchase cost over the par value is charged against additional paid-in capital (APIC) or retained earnings, as applicable. If the original issuance price is not known or determinable, the cost is first charged to APIC to the extent available, with any remaining amount charged to retained earnings.

The Company accounts for reissuance of treasury shares in accordance with ASC 505-30 – Equity: Treasury Stock. Treasury shares may be reissued for various purposes, including the settlement of employee equity awards, acquisitions, or other corporate purposes.

When treasury shares are reissued:

	·	The proceeds received upon reissuance are credited to treasury stock at the cost of the shares.

	·	Any difference between the reissuance price and the cost of the treasury shares is recorded as an adjustment to Additional Paid-In Capital (APIC).

	-	If the reissuance price exceeds the cost, the excess is credited to APIC.

	-	If the reissuance price is less than the cost and APIC related to treasury stock transactions is insufficient to absorb the difference, the remainder is charged to Retained Earnings.

The Company uses the cost method to account for treasury stock transactions. Reissued shares are included in the number of shares issued and outstanding as of the date of reissuance.

·	Stock Based Compensation

The Company accounts for stock-based compensation in accordance with ASC Topic 718-10, Compensation-Stock Compensation, which requires the measurement and recognition of compensation expense for all share-based payment arrangements related to the acquisition of goods and services from both non-employees and employees based on fair values of the shares at grant date. Market prices of the Company’s common stock at the respective issuance date, which represents the date of the final board approval for the issuance of the shares, is concluded to be the grant date, in accordance with ASC 718. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period.

Prepaid share-based compensation is recorded when the Company issues fully vested, nonforfeitable share-based payment awards to nonemployees on the grant date, when the nonemployee earns the right to receive and where no specific performance is required by the nonemployee to retain those equity instruments, in accordance with ASC 718-10-45-3. The prepayment is recorded where the shares are issued before the financial year end in accordance with the grant date and represents the fair value of goods or services that are to be received from the nonemployee subsequent to the financial period end.

Compensation cost for awards that do not have an established accounting grant date, but for which the service inception date has been established is based on the best estimate of fair value of Company's common stock at the end of each reporting period and a corresponding accrual is recorded. As of December 31, 2025, and June 30, 2025, $264,546 and $89,165 respectively, were recorded as accrued compensation cost for these share-based payment arrangements.

Share-based compensation cost is recognized over the requisite service period for employees and over the vesting period for nonemployees. The Company’s accounting policy is to recognize forfeitures as they occur.

F-14

Table of Contents

Share based compensation for non-employees for the three and six months ended December 31, 2025, were $309,292 and $601,983 respectively, and for three and six months ended December 31, 2024, were $273,853 and $545,859 respectively.

Share based compensation for employees for the three and six months ended December 31, 2025, were $48,957 and $118,065 respectively, and for three and six months ended December 31, 2024, were $95,096 and $201,680 respectively.

Share based compensation for directors for the three and six months ended December 31, 2025, were $8,346 and $16,691 respectively, and for three and six months ended December 31, 2024, were $0 respectively.

·	Retirement Plan Costs

Contributions to retirement plans (which are defined contribution plans) are charged to general and administrative expenses in the accompanying statements of operation as the related employee service are provided.

·	Related Parties

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The unaudited condensed consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

·	Commitments and Contingencies

The Company follows the ASC 450-20, Contingencies, to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

F-15

Table of Contents

Warrant

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

Equity-classified

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. Warrants classified as equity instruments are initially recognized at fair value within additional paid in capital and are not subsequently remeasured. The warrants have been assessed to meet the requirements for equity classification and accounted for as equity. Upon exercise of the warrants, the Company will record the proceeds received, together with the carrying value of the warrants, as an increase to common stock and additional paid-in capital. Warrants that expire unexercised will be derecognized with no impact on the statement of operations.

Liability-classified

For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance and are remeasured at each reporting date until settlement. Changes in fair value is recognized as a component of change in fair value of warrant liability in the condensed consolidated statements of operations and as a non-cash gain or loss in the condensed consolidated statement of comprehensive loss. Transaction costs allocated to warrants that are presented as a liability are immediately expensed in the consolidated statements of operations and comprehensive loss.

No liability classified warrants have been issued as of December 31, 2025.

·	Fair Value of Financial Instruments

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:

Level 1	Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2	Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3	Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, deposits with bank, loan and fee receivable, prepayments and other receivables, amounts due from related parties, accrued liabilities and other payables, loans payable, amounts due to related parties approximate their fair values because of the short maturity of these instruments.

·	Recent Accounting Pronouncements

During the six months ended December 31, 2025, there have been no new, or existing, recently issued accounting pronouncements that are of significance, or potential significance, that impact the Company’s unaudited condensed consolidated financial statements.

In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (“ASU 2025 01”). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Both early adoption and retrospective application are permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.

In November 2024, the FASB issued ASU No. 2024-04, Induced Conversions of Convertible Debt Instruments (Topic 470), which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The amendments in this update are effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.

F-16

Table of Contents

In March 2025, the FASB issued ASU No. 2025-02, Liabilities (405): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 122. The amendments in this Update are effective immediately and on a fully retrospective basis to annual periods beginning after December 15, 2024. The Company adopted this pronouncement and determined that there was no material effect of its disclosures in the unaudited condensed consolidated financial statement.

In May 2025, the FASB issued ASU No. 2025-04, Compensation—Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606). ASU 2025-04 revises the definition of the term performance condition for share-based consideration payable to a customer to incorporate conditions that are based on the volume or monetary amount of a customer’s purchases or potential purchases. ASU 2025-04 also eliminates the policy election to account for forfeitures as they occur for awards with service conditions. ASU 2025-04 also clarifies that ASC 606 variable consideration guidance does not apply to share-based payments to customers; instead, vesting probability should be assessed solely under ASC 718, Compensation—Stock Compensation. ASU 2025-04 is effective for the Company’s annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods, with early adoption permitted. ASU 2025-04 may be applied on either a modified retrospective basis or on a retrospective basis. The Company is currently evaluating the effect of this pronouncement on its disclosures.

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Account Receivable and Contract Assets. This update introduces a practical expedient for all entities when estimating expected credit losses on current accounts receivable and current contract assets arising from revenue transactions accounted for under Topic 606. The expedient allows entities to assume current conditions as of the balance sheet date remain unchanged over the remaining life of the asset. The amendments are required to be applied prospectively and are effective for annual and interim periods beginning after December 15, 2025. Early adoption is permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. This update provides amendments to clarify and modernize the accounting for costs incurred to develop or acquire internal-use software. The amendments address the capitalization of implementation costs by utilizing a principles-based approach and consolidates website development guidance under Subtopic 350-40. The amendments can be applied prospectively, modified prospectively, or retrospectively and are effective for annual and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.

In September 2025, the FASB issued ASU No. 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract. This update introduces a scope exception to derivative accounting for certain contracts with underlyings tied to operations or activities specific to one of the parties. Additionally, the update clarifies that share-based noncash consideration received from a customer should be accounted for under Topic 606 until the right to receive or retain the consideration becomes unconditional. The amendments can be applied prospectively or modified retrospectively and are effective for annual and interim periods beginning after December 15, 2026. While the Company has assessed that there is no significant impact to the condensed consolidated financial statements, the impact of this pronouncement on disclosures contained in notes thereto is being evaluated.

In December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. This update clarifies the applicability, form and content, and interim disclosure requirements in ASC Topic 270 and enhances navigability of the interim reporting guidance. The amendments are effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, for public business entities and after December 15, 2028, for entities other than public business entities. Early adoption is permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.

In December 2025, the FASB issued ASU 2025-12, “Codification Improvements,” which updates the FASB Accounting Standards Codification to clarify, correct errors, and improve the overall usability of GAAP. The improvements consist of narrow-scope amendments, technical corrections, clarification of existing guidance, and updates to clarify the appropriate scope and application of certain disclosure requirements. ASU 2025-12 is effective for annual and interim periods beginning after December 15, 2026. Early adoption is permitted. The Company is currently evaluating the effect this pronouncement on the disclosures contained in the notes to the condensed consolidated financial statements.

The Company is currently reviewing all recently issued, but not yet effective, accounting pronouncements and is evaluating the impact of these pronouncements on the relevant disclosures. The Company believes the future adoption of any such pronouncements may not be expected to cause a material impact on its financial condition or the results of its operations.

F-17

Table of Contents

NOTE 3 – BUSINESS SEGMENT INFORMATION

Currently, the Company operates three business segments for the purpose of assessing performance and making operating decisions, mainly operating in:

(i)	Trading and production of building materials and renewable commodities;
(ii)	Holding of real property; and
(iii)	Licensor of proprietary pyrolysis technology.

The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer (CEO). The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as three operating segments, which are the same as its reporting segments.

The operating results of the reportable segments for the three and six months ended December 31, 2025 and 2024 are shown in the following tables:

	Three Months ended December 31, 2025
	Trading and production of building materials and renewable commodities			Holding property			Licensor of proprietary pyrolysis technology		Corporate unallocated			Consolidated

Revenue	$	4,583		$	-		$	-	$	96		$	4,679
Cost of revenue		(855	)		-			-		(31	)		(886	)
Gross profit		3,728			-			-		65			3,793
Selling, general & administrative expenses		(512,890	)		(21,475	)		38		(592,101	)		(1,126,428	)
Other operating expenses		(57,241	)		-			-		-			(57,241	)
(Loss) Profit from operations		(566,403	)		(21,475	)		38		(592,036	)		(1,179,876	)
Interest income		4,779			-			-		-			4,779
Unrealized foreign exchange gain		-			-			118		234,277			234,395
Other income		-			-			6,626		-			6,626
(Loss) Profit before income tax		(561,624	)		(21,475	)		6,782		(357,759	)		(934,076	)
Income tax		-			-			-		-			-
Net (loss) income	$	(561,624	)	$	(21,475	)	$	6,782	$	(357,759	)	$	(934,076	)

Total assets at December 31, 2025	$	8,449,214		$	247		$	30,192,771	$	667,787		$	39,310,019

	Three Months ended December 31, 2024
	Trading and production of building materials and renewable commodities			Holding property			Licensor of proprietary pyrolysis technology			Corporate unallocated			Consolidated

Revenue	$	460		$	-		$	-		$	1,963		$	2,423
Cost of revenue		(8,181	)		-			-			(1,371	)		(9,552	)
Gross (loss) profit		(7,721	)		-			-			592			(7,129	)
Selling, general & administrative expenses		(2,051,939	)		(174,626	)		6,729			(164,113	)		(2,383,949	)
Other operating expenses		(50,698	)		-			-			-			(50,698	)
(Loss) Profit from operations		(2,110,358	)		(174,626	)		6,729			(163,521	)		(2,441,776	)
Interest expense		(5,895	)		-			-			-			(5,895	)
Rental income		-			18,204			-			-			18,204
Interest income		16,272			-			-			-			16,272
Unrealized foreign exchange gain (loss)		2,886			-			(1,129	)		(443,778	)		(442,021	)
Gain on disposal of property, plant and equipment		-			161,156			-			-			161,156
Other income		(4,959	)		4,690			-			-			(269	)
(Loss) Profit before income tax		(2,102,054	)		9,424			5,600			(607,299	)		(2,694,329	)
Income tax		-			-			-			-			-
Net (loss) profit	$	(2,102,054	)	$	9,424		$	5,600		$	(607,299	)	$	(2,694,329	)

Total assets at December 31, 2024	$	8,364,024		$	548,866		$	30,193,938		$	638,772		$	39,745,600

F-18

Table of Contents

	Six Months ended December 31, 2025
	Trading and production of building materials and renewable commodities			Holding property			Licensor of proprietary pyrolysis technology			Corporate unallocated			Consolidated

Revenue	$	6,808		$	-		$	-		$	140		$	6,948
Cost of revenue		(2,190	)		-			-			(31	)		(2,221	)
Gross profit		4,618			-			-			109			4,727
Selling, general & administrative expenses		(1,034,493	)		(21,475	)		(12	)		(959,424	)		(2,015,404	)
Other operating expenses		(113,137	)		-			-			-			(113,137	)
Loss from operations		(1,143,012	)		(21,475	)		(12	)		(959,315	)		(2,123,814	)
Interest income		11,823			-			-			-			11,823
Unrealized foreign exchange gain		-			-			210			251,524			251,734
Other income		-			-			6,626			-			6,626
(Loss) Profit before income tax		(1,131,189	)		(21,475	)		6,824			(707,791	)		(1,853,631	)
Income tax		-			-			-			-			-
Net (loss) profit	$	(1,131,189	)	$	(21,475	)	$	6,824		$	(707,791	)	$	(1,853,631	)

Total assets at December 31, 2025	$	8,449,214		$	247		$	30,192,771		$	667,787		$	39,310,019

	Six Months ended December 31, 2024
	Trading and production of building materials and renewable commodities			Holding property			Licensor of proprietary pyrolysis technology			Corporate unallocated			Consolidated

Revenue	$	126,030		$	-		$	-		$	1,963		$	127,993
Cost of revenue		(57,777	)		-			-			(1,371	)		(59,148	)
Gross profit		68,253			-			-			592			68,845
Selling, general & administrative expenses		(2,705,430	)		(213,228	)		-			(280,220	)		(3,198,878	)
Other operating expenses		(105,816	)		-			-			-			(105,816	)
Loss from operations		(2,742,993	)		(213,228	)		-			(279,628	)		(3,235,849	)
Interest expense		(14,904	)		-			-			(86,456	)		(101,360	)
Interest income		38,809			-			-			-			38,809
Rental income		-			34,100			-			-			34,100
Unrealized foreign exchange gain (loss)		2,886			-			(1,129	)		274,923			276,680
Gain from insurance claims		-			481,513			-			-			481,513
Gain on disposal of property, plant and equipment		-			161,156			-			-			161,156
Other income		647			4,690			-			-			5,337
(Loss) Profit before income tax		(2,715,555	)		468,231			(1,129	)		(91,161	)		(2,339,614	)
Income tax		-			-			-			-			-
Net (loss) profit	$	(2,715,555	)	$	468,231		$	(1,129	)	$	(91,161	)	$	(2,339,614	)

Total assets at December 31, 2024	$	8,364,024		$	548,866		$	30,193,938		$	638,772		$	39,745,600

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:

	Three Months ended December 31,				Six Months ended December 31,
	2025		2024		2025		2024

Malaysia	$	243	$	2,423	$	287	$	2,873
United States of America		4,436		-		6,661		125,120
	$	4,679	$	2,423	$	6,948	$	127,993

F-19

Table of Contents

NOTE 4 – DEPOSIT WITH BANKS

At December 31, 2025, and June 30, 2025, the interest rates and maturities of deposits with banks is 3.92% (June 30, 2025: 1.98% to 4.64%) per annum and 91 days (June 30, 2025 :120 to 270 days), respectively.

NOTE 5 – INVENTORIES

Inventories as of December 31, 2025, and June 30, 2025, consisted of the following:

	December 31, 2025		June 30, 2025

Manufactured bio produce	$	80,840	$	77,399
Trading goods		205,867		207,162
	$	286,707	$	284,561

Trading goods represent bio asphalt products purchased from an external supplier.

NOTE 6 – OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS

Other receivables, deposits and prepayments as of December 31, 2025, and June 30, 2025, consist of the following:

	December 31, 2025			June 30, 2025

Deposits	$	6,912		$	6,781
Other receivables		37,338			41,976
	$	44,250		$	48,757
Less: impairment on other receivables		(34,584	)		(33,110	)
Other receivables and deposits, net	$	9,666		$	15,647
Prepayments		109,140			46,605
Prepaid share based compensation-nonemployees (current portion)		45,415			455,291
	$	164,221		$	517,543

Prepaid share based compensation-nonemployees (non-current portion)	$	118,898		$	126,047

NOTE 7 – PROPERTY, PLANT AND EQUIPMENT

A summary of property, plant and equipment as of December 31, 2025, and June 30, 2025, is as follows:

	December 31, 2025			June 30, 2025

Plant and machinery	$	2,056,949		$	1,843,774
Office equipment		6,239			6,161
Computers		15,837			14,233
Motor vehicles		4,730			4,240
Furniture and fittings		4,932			4,421
Renovation		4,943			4,431
		2,093,630			1,877,260
Less: accumulated depreciation		(630,322	)		(480,820	)
Foreign exchange adjustment		66,525			178,544
	$	1,529,833		$	1,574,984

Depreciation expense for the three months ended December 31, 2025 and 2024, totaled $56,517 and $67,145, respectively.

Depreciation expense for the six months ended December 31, 2025 and 2024, totaled $111,676 and $137,375, respectively.

There has been no impairment charge for the three months ended December 31, 2025 and 2024.

F-20

Table of Contents

NOTE 8 –INTANGIBLE ASSETS

The intangible assets comprise (i) intellectual property in the form of proprietary trade secrets (“IP”) with a value of $30,192,771 known as “Catalytic Biofraction Process”, whereby, the Company’s subsidiary VRAP is the beneficial and/or registered proprietor pursuant to an Intellectual Property Transfer Agreement dated October 15, 2025 between BRL and VRAP and (ii) an exclusive license for the Catalytic Biofraction Process assigned to Verde Malaysia by VRAP for the operation of the IP in the state of Sabah, Malaysia of MYR 14,000,000 ($3,458,420).

The “Catalytic Biofraction Process” is a slow pyrolysis process using a proprietary catalyst to depolymerize palm biomass waste (empty fruit bunches or palm kernel shells) in temperature range of 350 degrees Celsius to 500 degrees Celsius to yield commercially valuable bio products: bio-oil, wood vinegar (pyroligneous acid), biochar and bio-syngas. The intellectual property is a second-generation pyrolysis process where non-food feedstock like palm biomass waste is used as feedstock. Upon fulfilling UN’s (United Nations) ACM 22 protocol as well as LCA (Life Cycle Assessment) requirements, it is anticipated that the by products from this IP would lead to certification and issuance of Carbon Avoidance Credits as well as Carbon Removal Credits to generate carbon revenue for the Company.

The Company has identified these intangible assets as indefinite life intangible assets as there are currently no legal, competitive, economic or other factors that materially limit the useful life of the Company’s intangible assets.

ASC 350-30-35, Intangibles - Goodwill and Other, provides for an option for an evaluating company to first perform a qualitative assessment to determine whether it is more likely than not that an asset is impaired. If the qualitative assessment supports that it is more likely than not that the fair value of the asset exceeds its carrying value, a quantitative impairment test is not required. If the qualitative assessment does not support the fair value of the asset, then a quantitative assessment is performed. Our annual impairment assessment of our identifiable indefinite lived intangible assets is performed as of the fourth quarter of each year. An assessment is performed at other times if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below its carrying value. If the carrying value of the intangible assets exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

As of June 30, 2025, the Company performed a qualitative assessment, during the fourth quarter of 2025, to determine whether it was more likely than not that the carrying amounts of its intangible assets were impaired. This assessment considered a number of qualitative factors, including but not limited to:

	·	Macroeconomic conditions,
	·	Industry and market trends,
	·	Cost factors,
	·	Overall financial performance of the asset,
	·	Legal and regulatory environment, and
	·	Relevant internal reporting and management’s plans.

Based on this qualitative assessment, management did not identify any events or changes in circumstances that would indicate that the carrying amounts of the Company’s intangible assets are not recoverable. The qualitative impairment assessment of the indefinite intangible assets conducted in June 2025 indicated that the fair value of such assets exceeded their carrying value and therefore were not at risk of impairment. Accordingly, no quantitative impairment test was deemed necessary, and no impairment losses were recognized for the year ended June 30, 2025. The management evaluated the situation for the six months ended December 31, 2025, and determined that no significant changes had occurred. Accordingly, it is concluded that no impairment is required.

NOTE 9 – ASSETS HELD FOR SALE

At December 31, 2025, and June 30, 2025, assets held for sale are as follows:

	December 31, 2025			June 30, 2025

Motor vehicles	$	9,866		$	9,866
Less: impairment		(5,866	)		(5,866	)
	$	4,000		$	4,000

On June 27, 2024, the Company, through its wholly-owned subsidiary Verde Renewables, a company incorporated under the laws of the State of Missouri, entered into a Consignment Contract with ED’s Machinery LLC (“EDM”) to dispose plant and machinery and motor vehicles with a carrying amount of $606,043. The disposal was pending completion as at June 30, 2024, and thus the assets had been presented separately in the balance sheets as assets held for sale. The disposal of assets with carrying values totaling $596,176 was completed as of June 30, 2025. The remaining asset comprises a vehicle that will be sold for its parts, and accordingly, an impairment of $0 and $5,866 were recognized during the financial period/year ended December 31, 2025 and June 30, 2025.

F-21

Table of Contents

NOTE 10 – SECURITY DEPOSIT

At December 31, 2025, and June 30, 2025, security deposit consists of the following:

December 31,

2025

June 30,

2025

Security deposit

- Factory site

80,000

On March 2, 2022, the Company, through VRAP, entered into a Commercial Lease Agreement and Option to Purchase (“Segama Lease Agreement”) the factory site from Segama Ventures for a lease term of seven (7) years (“Lease Term”) at a monthly rental of MYR 36,000 ($8,571). The rental for the entire Lease Term amounting to the sum of MYR 3,024,000 ($720,000) (the “Lease Payment”) was paid in advance upon commencement of the Segama Lease Agreement together with a payment of security deposit for the sum of MYR 336,000 ($80,000) (the “Security Payment”).

NOTE 11 – AMOUNTS DUE TO/FROM RELATED PARTIES (INCLUDING CHAIRMAN AND CHIEF EXECUTIVE OFFICER)

The following breakdown of the balances due to/from related parties and director, consisted of:-

	December 31, 2025		June 30, 2025

Amount due to related parties
Borneo Oil Corporation Sdn (“BOC”) (#2)	$	72,822	$	72,869
Borneo Oil Berhad (“BOB”) (#1)		3,007		3,007
Taipan International Limited (#3)		119,153		119,153
Borneo Energy Sdn Bhd (#1)		16,298		16,356
Victoria Capital Sdn Bhd (#4)		6,176		5,913
Makin Teguh Sdn Bhd (#1)		19,379		19,379
J. Ambrose & Partners (#5)		76,336		75,904
SB Resorts Sdn Bhd (#2)		6,917		6,622
SB Supplies & Logistics Sdn Bhd (#1)		4,817		4,612
Borneo Eco Food Sdn. Bhd. (#1)		1,210		1,159
	$	326,115	$	324,974

Amount due from a related party
Vetrolysis Limited (#6)	$	-	$	100

Amount due to director
Mr. Jack Wong (#7)	$	4,302	$	209,640

F-22

Table of Contents

NOTE 12 - LEASES

The Company adopted ASU No. 2016-02, Leases and determines whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if we obtain the rights to direct the use of and to obtain substantially all of the economic benefit from the use of the underlying asset. Some of our leases include both lease and non-lease components which are accounted for as a single lease component as the Company has elected the practical expedient. Some of the operating lease agreements include variable lease costs, primarily taxes, insurance, common area maintenance or increases in rental costs related to inflation. Substantially all of our equipment leases and some of our real estate leases have terms of less than one year and, as such, are accounted for as short-term leases as we have elected the practical expedient.

Operating leases are included in the right-of-use lease assets, other current liabilities and long-term lease liabilities on the unaudited condensed consolidated balance sheet. Right-of-use assets and lease liabilities are recognized at each lease’s commencement date based on the present values of its lease payments over its respective lease term. When a borrowing rate is not explicitly available for a lease, the incremental borrowing rate is used based on information available at the lease’s commencement date to determine the present value of its lease payments. Operating lease payments are recognized on a straight-line basis over the lease term.

The table below presents the lease-related assets and liabilities recorded on the balance sheet.

	December 31, 2025			June 30, 2025

Assets
Right-of-use asset (#1)	$	720,000		$	720,000
Right-of-use asset (#2)		162,335			162,092
Total RoU assets		882,335			882,092
Less: Accumulated amortization		(438,073	)		(363,717	)
	$	444,262		$	518,375

Liabilities
Current:
Operating lease liabilities	$	41,032		$	38,311

Non-current:
Operating lease liabilities		71,209			91,639

Total lease liabilities	$	112,241		$	129,950

As of December 31, 2025, right-of-use assets were $444,262 and lease liabilities were $112,241.

As of June 30, 2025, right-of-use assets were $518,375 and lease liabilities were $129,950.

For the three months ended December 31, 2025 and 2024, the amortization charge on right-of use assets was $37,186 and $32,775, respectively.

For the six months ended December 31, 2025 and 2024, the amortization charge on right-of-use was $74,356 and $63,308, respectively.

(#1) This leasing arrangement for the lease of the Segama factory amounting to $720,000 is for a lease term of seven (7) years commencing March 2, 2022.

There are no corresponding lease liabilities recorded, as the lease payments for the entire lease period have been paid upfront upon inception of the agreement.

(#2) The Company through its wholly owned subsidiary VRI entered into various lease arrangements for the use of motor vehicles for lease term of three (3) to four (4) years which expire at various dates through 2029. Certain of the lease arrangements contain option to purchase at an agreed consideration as stated in the respective lease agreement. The Company’s lease agreements do not contain any material restrictive covenants.

F-23

Table of Contents

The table below presents the information related to weighted average discount rate and the remaining lease term (years) of the operating leases.

	Six Months ended December 31,
	December 31, 2025			June 30, 2025
Operating leases
Weighted average discount rate		9.05	%		9.00	%
Weighted average remaining lease term (years)		2.60			3.10

The accretion of lease liability for the three and six months ended December 31, 2025, were $2,642 and $5,480, respectively and for the three and six months ended December 31, 2024, were $986 and $2,241, respectively.

The Company excludes short-term leases (those with lease terms of less than one year at inception) from the measurement of lease liabilities or right-of-use assets. The following tables summarize the lease expense for the periods.

	Six Months ended December 31,
	2025		2024

Finance lease cost:
Interest on lease liabilities (per ASC 842)	$	-	$	5,681

Operating lease cost:
Operating lease expense (per ASC 842)		79,836		65,549

Total lease expense	$	79,836	$	71,230

Components of Lease Expense

The Company recognizes operating lease expense on a straight-line basis over the term of the operating leases, comprising interest expense determined using the effective interest method, and amortization of the right-of-use asset, as reported within “general and administrative” expense on the accompanying unaudited condensed consolidated statement of operations.

Finance lease expense comprises of interest expenses determined using the effective interest method.

Future Contractual Lease Payments as of December 31, 2025

The below table summarizes (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest, and (iii) present value of future lease payments for the next three years and thereafter ending December 31:

Years ending December 31,	Operating lease amount

2026	$	49,469
2027		48,435
2028		26,984
Thereafter		2,249

Total minimum lease liabilities payment		127,137
Less: imputed interest		(14,896	)
Present value of lease liabilities	$	112,241

Representing:-
Current liabilities	$	41,032
Non-current liabilities		71,209
Present value of lease liabilities	$	112,241

F-24

Table of Contents

NOTE 13 – WARRANTS

On October 31, 2025, the Company entered into a securities purchase agreement (the “Ergon Purchase Agreement”) with Ergon, pursuant to which Ergon purchased a total of 24,943,876 shares (the “Ergon Shares”) of the Company’s common stock and a warrant (the “Warrant”) to purchase 24,943,876 shares of common stock (the “Warrant Shares”), at a combined purchase price of $0.08018 per share (the “Offering Price”), which represents a five percent (5%) discount to the volume-weighted average price of the Company’s common stock for the thirty (30) trading days immediately preceding the closing of the offering of the Ergon Shares and Warrant by the Company to Ergon (the “Offering”). No warrants have been exercised from the date of issuance through December 31, 2025.

The unregistered Warrants are exercisable beginning on October 31, 2025 and expires on October 31, 2030, and was issued in certificated form. The exercise price of $0.08018 per share and number of Warrant Shares issuable upon exercise are subject to customary adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting the Common Stock, but are not subject to price-based anti-dilution protection.

The Warrant is exercisable in whole or in part for cash, except that if, at the time the holder exercises the Warrant, a registration statement registering the resale of the Warrant Shares under the Securities Act of 1933, as amended (the “Securities Act”), is not then effective or available for the issuance of such Warrant Shares, then in lieu of making the cash exercise payment, the holder may elect to exercise the Warrant on a “cashless” basis and receive a net number of Warrant Shares determined according to a formula set forth in the Common Stock Purchase Warrant.

The Company evaluated the Warrants in accordance with ASC 815-40 and determined that they are indexed to the Company’s own stock and meet the criteria for equity classification. Accordingly, the Warrants were recorded in additional paid-in capital at their issuance-date fair value and are not subsequently remeasured.

The Warrants were issued in connection with common stock and the proceeds were allocated between the warrants and the related financial instrument based on their relative fair values within additional paid-in capital.

NOTE 14 - STOCKHOLDERS’ EQUITY

Authorized Stock

The Company has authorized 10,000,000,000 shares of common stock and 50,000,000 shares of preferred stock, both with a par value of 0.001 per share. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

Preferred stock outstanding

There are no shares of preferred stock outstanding as of December 31, 2025, and June 30, 2025.

Common stock outstanding

F-25

Table of Contents

On July 31, 2024, the Company issued 1,000,000 of the Company’s restricted shares of Common Stock each to Dr. Nam Tran and Dr. Raymond Powell as part of their compensation packages in the Services Agreements that the Company entered into with Dr. Nam Tran and Dr. Raymond Powell on April 20, 2024, for the service period from May 1, 2024, to April 30, 2025.

On August 8, 2024, the Company issued 700,000 of the Company’s restricted shares of Common Stock to Dale Ludwig as part of the compensation package in the Services Agreement that the Company entered into with Dale Ludwig on June 1, 2024, for the service period from June 1, 2024, to April 30, 2025.

On July 24, 2024, the Company issued 3,194,443 restricted shares of Common Stock for $287,500 at $0.09 per share to four U.S. shareholders and 6,005,000 restricted shares of Common Stock for $600,500 at $0.10 per share to twenty U.S. shareholders and one non-U.S. shareholder.

On August 9, 2024, the Company issued 888,888 restricted shares of Common Stock for $80,000 at $0.09 per share to one U.S. shareholder and 11,840,000 restricted shares of Common Stock for $1,184,000 at $0.10 per share to twenty-three U.S. shareholders and one non-U.S. shareholder.

On August 16, 2024, the Company issued 9,655,542 shares of the Company’s restricted Common Stock at the price of $0.07 per share to Borneo Oil Berhad in relation to the Settlement of Debts Agreement (the “SDA Agreement”) and a two-year term period Promissory Note entered into with its former indirect wholly-owned subsidiary Champmark Sdn Bhd (“CSB”) and CSB’s creditor Borneo Oil Corporation Sdn Bhd (the “Creditor”) to settle in full a total of $675,888 of CSB’s account payable. On March 13, 2023, the Company and CSB entered into an SDA Agreement and a two-year term period Promissory Note with the Creditor to settle in full a total of $675,888 of CSB’s account payable to the Creditor either in cash or by the issuance of new restricted shares of the Company’s Common Stock at a price of $0.07 per share. As set out in the SDA Agreement, the new restricted shares for settlement of the account payable to the Creditor shall be issued to the Creditor or its nominee. On August 16, 2024, the Company entered into a Supplementary Agreement to the SDA Agreement and Promissory Note with the Creditor to convert the total amount of $675,888 into 9,655,542 shares of the Company’s restricted Common Stock at the agreed conversion price of $0.07 per share for issuance on August 16, 2024.

On August 26, 2024, the Company issued 722,221 restricted shares of Common Stock for $65,000 at $0.09 per share to three U.S. shareholders, 3,990,000 restricted shares of Common Stock for $399,000 at $0.10 per share to six U.S. shareholders and two non U.S. shareholders.

On August 30, 2024, the Company issued 1,350,000 of the Company’s restricted shares of Common Stock to Jeremy P. Concanon, Chief Growth Officer of the Company, as part of the compensation package in the Services Agreement that the Company entered into with Jeremy P. Concanon on July 31, 2024.

On August 30, 2024, the Company issued 670,000 of the Company’s restricted shares of Common Stock to Eric Bava, Chief Operating Officer of the Company, as part of the compensation package in the Employment Agreement that the Company entered into with Eric Bava on October 1, 2023 for his first year of service from October 1, 2023 to September 30, 2024.

On September 16, 2024, the Company issued 222,222 restricted shares of Common Stock for $20,000 at $0.09 per share to one U.S. shareholder and 350,000 restricted shares of Common Stock for $35,000 at $0.10 per share to two U.S. shareholders

F-26

Table of Contents

On October 16, 2024, the Company issued 800,000 restricted shares of Common Stock for $80,000 at $0.10 per share to three U.S. shareholders.

On November 27, 2024, the Company cancelled 450,000 restricted shares of Common Stock that were previously issued to two U.S. shareholders.

On January 2, 2025, the Company issued a total of 3,277,775 restricted shares of Common Stock, comprising 2,500,000 restricted shares of Common Stock for $250,000 at $0.10 per share to seven U.S. shareholders and 777,775 restricted shares of Common Stock for $70,000 at $0.09 per share to six U.S. shareholders.

On January 2, 2025, the Company issued 4,656,550 of the Company’s restricted shares of Common Stock to Aegis Ventures Limited, being 50% of the 0.75% of the Company’s total shares outstanding pursuant to the terms of the consulting services agreement that the Company, through its wholly-owned subsidiary Verde Renewables, Inc., entered into with AUM on November 29, 2024, to engage AUM as a Capital Markets, Investor Relations and Media Relations Advisor to provide advice to the Company on its preparations for an equity raise and the planned uplisting to NASDAQ. The remaining 4,656,550 shares to be issued within three days following the Company’s listing on the NASDAQ.

On January 3, 2025, the Company issued 50,000 of the Company’s restricted Common Shares to Hannah Bruehl. The Company agreed to issue 50,000 of the Company’s restricted shares of Common Stock to Hannah Bruehl, Executive Assistant to C-Suite Executives of the Company for service period from September 3, 2024 to September 2, 2025, as part of the compensation package in the Employment Agreement signed on September 3, 2024.

On January 6, 2025, the Company cancelled 200,000 restricted Common Shares that were previously issued to two U.S. shareholders.

On February 18, 2025, the Company issued a total of 3,905,555 restricted shares of Common Stock, comprising 3,000,000 restricted shares of Common Stock for $300,000 at $0.10 per share to one non-U.S. shareholder, 850,000 restricted shares of Common Stock for $85,000 at $0.10 per share to seven U.S. shareholders and 55,555 restricted shares of Common Stock for $5,000 at $0.09 per share to one U.S. shareholder.

On April 22, 2025, the Company cancelled 150,000 restricted Common Shares that were previously issued to one U.S. shareholder.

On May 20, 2025, the Company issued 249,999 restricted shares of Common Stock for $24,999.90 at $0.10 per share to one U.S. shareholder and one non-U.S. shareholder.

On June 1, 2025, the Company issued 1,500,000 shares of the Company’s restricted Common Stock to Sundeo Pty Ltd, an affiliate designated by C-Twelve, pursuant to the C-Twelve Agreement.

On June 1, 2025, the Company issued 350,000 of the Company’s restricted shares of Common Stock to Karl Strahl, a Director of the Company, as part of the compensation package in the Director Appointment Agreement that the Company entered into with Karl Strahl on May 1, 2025.

On July 1, 2025, the Company issued a total of 7,744,445 restricted shares of common stock which were committed to be issued as of June 30, 2025, comprising 4,444,445 restricted shares of common stock for $400,000 at $0.09 per share to one non-U.S. shareholder and 3,300,000 restricted shares of common stock for $264,000 at $0.08 per share to one non-U.S. shareholder and seven U.S. shareholders.

On July 1, 2025, the Company issued the second tranche of 1,000,000 of the Company’s restricted shares of common stock to Dr. Raymond Powell as part of the compensation package in the NIE agreement.

On July 28, 2025, the Company issued a total of 187,500 restricted shares of common stock for $15,000 at $0.08 per share to one U.S. shareholder.

On September 12, 2025, the Company issued a total of 5,412,500 restricted shares of common stock for $433,000 at a price of $0.08 per share to three non-U.S. shareholders.

On October 31, 2025, the Company entered into a securities purchase agreement (the “Ergon Purchase Agreement”) with Ergon, pursuant to which Ergon purchased a total of 24,943,876 unregistered shares (the “Ergon Shares”) of the Company’s common stock and an unregistered warrant (the “Warrant”) to purchase 24,943,876 shares of common stock (the “Warrant Shares”), at a combined purchase price of $0.08018 per share (the “Offering Price”), which represents a five percent (5%) discount to the volume-weighted average price of the common stock for the thirty (30) trading days immediately preceding the closing of the offering of the Ergon Shares and Warrant by the Company to Ergon (the “Offering”).

F-27

Table of Contents

On September 8, 2023, the Company, through its wholly-owned subsidiary Verde Renewables entered into a Service and Stock Cancellation Agreement with EMGTA LLC to cancel the Services Agreement dated December 1, 2022, including the cancellation of 375,000 restricted Common shares issued at $0.20 on December 31, 2022, totaling $75,000 as consideration for certain services. The cancellation is still in process.

Not considering the commitment to cancel shares as above, there were 1,294,224,767 and 1,262,680,891 (including 7,744,445 shares committed to be issued for private placement subsequent to financial year end) shares of common stock issued and outstanding at December 31, 2025, and June 30, 2025 respectively.

Apart from the common stock committed to be issued as disclosed in Note 20, the Company has no stock option plan, or other dilutive securities as of December 31, 2025.

NOTE 15 - NET LOSS PER SHARE

The following table sets forth the computation of basic and diluted net (loss) income per share for the respective years:

	Three Months ended December 31,						Six Months ended December 31,
	2025			2024			2025			2024

Net loss	$	(934,076	)	$	(2,694,329	)	$	(1,853,631	)	$	(2,339,614	)
Less: Net loss attributable to non-controlling interest		2,700			27			2,700			27
Net loss attributable to Verde Resources, Inc. shareholders	$	(931,376	)	$	(2,694,302	)	$	(1,850,931	)	$	(2,339,587	)

Weighted average common shares outstanding:
- Basic		1,282,721,100			1,237,746,936			1,271,187,386			1,228,662,486
- Diluted		1,282,721,100			1,237,746,936			1,271,187,386			1,228,662,486

Net loss per share:
- Basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
- Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

For the three and six months ended December 31, 2025 and 2024, diluted weighted-average common shares outstanding is equal to basic weighted-average common shares, due to the Company’s net loss position. Hence, potential dilutive common stock equivalents, including warrants and those granted but are non-vested and are non-forfeitable shares issued to nonemployee, employee and director were excluded in the computation of diluted net loss per share since such inclusion would have been antidilutive.

The denominator used in the computation of basic and diluted net (loss) income per share is as follows:

	Three Months ended December 31,						Six Months ended December 31,
	2025			2024			2025			2024

Weighted average common shares outstanding		1,286,090,894			1,241,444,937			1,275,511,029			1,232,131,001
Less: weighted average non-vested shares		(3,369,794	)		(3,698,001	)		(4,323,643	)		(3,468,515	)
Weighted average of common shares		1,282,721,100			1,237,746,936			1,271,187,386			1,228,662,486

F-28

Table of Contents

NOTE 16 - INCOME TAX

For the six months ended December 31, 2025 and 2024, the local (United States of America) and foreign components of (loss) profit before income taxes were comprised of the following:

	Six Months ended December 31,
	2025			2024

Tax jurisdiction from:
- Local (US regime)	$	(1,819,919	)	$	(2,352,785	)
- Foreign, including
British Virgin Islands		200,084			220,074
Malaysia		(248,399	)		(205,715	)
Labuan, Malaysia		14,603			(1,188	)

Loss before income taxes	$	(1,853,631	)	$	(2,339,614	)

The provision for income taxes consisted of the following:

	Six Months ended December 31,
	2025		2024

Current tax:
- Local	$	-	$	-
- Foreign		-		-

Deferred tax
- Local		-		-
- Foreign		-		-

Income tax expense (benefit)	$	-	$	-

The effective tax rate in the periods presented reflects the impact of losses incurred across various tax jurisdictions, each with different applicable income tax rates.

The Company mainly operates in the United States and Malaysia and is subject to taxes in the jurisdictions in which they operate, as follows:

United States of America

The Company, VRI, VerdePlus and VLI are subject to the tax laws of United States of America. The U.S. corporate income tax rate is 21% effective January 1, 2018. The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits in its income tax provision. The Company has not accrued or paid interest or penalties which were not material to its results of operations for the periods presented.

The Company has provided for a full valuation allowance against the deferred tax assets of $2,314,599 on the expected future tax benefits from the net operating loss (“NOL”) carry forwards of $11,021,901 as the management believes it is more likely than not that these assets will not be realized in the future.

Net Operating Losses (NOLs) generated prior to January 1, 2018, are able to be carried forward up to twenty subsequent years. Any NOLs created for tax years subsequent to that may be carried forward indefinitely. However, any NOLs arising from tax years ending after December 31, 2020, can only be used to offset up to 80% of taxable income.

For the six months ended December 31, 2025 and 2024, there was no operating income under the U.S. tax regime.

BVI

Under current BVI law, VRAP is not subject to tax on income.

F-29

Table of Contents

Labuan

Under the current laws of the Labuan applicable to BRL, income derived from an intellectual property right is subject to tax under the Malaysian Income Tax Act 1967 (ITA) at 24% of its chargeable income. However, BRL is not subject to income tax, given that it was a net loss position during the current period presented. BRL was administratively dissolved by being struck off the registers of the Labuan Financial Services Authority on October 19, 2025.

Malaysia

The Company’s subsidiaries, Verde Malaysia and Wision, are registered in Malaysia and are subject to the Malaysian corporate income tax at a standard income tax rate of 24% on chargeable income.

The operation in Malaysia incurred $1,165,041 of cumulative net operating losses as of December 31, 2025, which can be carried forward to offset future taxable income. The net operating loss are allowed to be carried forward up to a maximum of ten (10) years of assessments under the current tax legislation in Malaysia. The Company has provided for a full valuation allowance against the deferred tax assets of $279,610 on the expected future tax benefits from the net operating loss (“NOL”) carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

	Six Months ended December 31,
	2025			2024

Loss before income taxes	$	(234,620	)	$	(305,808	)
Statutory income tax rate		24	%		24	%
Income tax expense at statutory rate		(56,309	)		(73,394	)
Non-deductible items		26,671			26,122
Tax losses unable to be carried forward		(3,505	)		1,255
Valuation allowance		33,143			46,017
Income tax expense	$	-		$	-

The following table sets forth the significant components of the deferred tax assets of the Company:

	December 31, 2025			June 30, 2025

Deferred tax assets:
Net operating loss carryforwards, from
US tax regime	$	2,314,599		$	2,090,051
Malaysia tax regime		279,610			249,972
Less: valuation allowance		(2,594,209	)		(2,340,023	)
Deferred tax assets, net	$	-		$	-

The Company has recorded valuation allowances for certain tax attribute carry forwards and other deferred tax assets due to uncertainty that exists regarding future realizability. If in the future the Company believes that it is more likely than not that these deferred tax benefits will be realized, the majority of the valuation allowances will be reversed in the unaudited condensed consolidated statement of operations. The Company did not have uncertainty tax positions or events leading to uncertainty tax position within the next 12 months.

F-30

Table of Contents

NOTE 17 - RELATED PARTY TRANSACTIONS

	Six Months ended
	December 31,
	2025		2024
Related party transactions:
Rental income:
Mr. Jack Wong (#1)	$	-	$	30,000
SB Resorts Sdn Bhd (#2)	$	-	$	2,053
Interest expense paid to:
BOC (#2)	$	-	$	1,738
Sale of property:
Mr. Jack Wong (#1)	$	-	$	857,500
Creative and technical services fee paid to:
Mr. Teo Zye Keun (#3)	$	37,756	$	-

Related party balances are disclosed in Note 11.

(#1) Mr. Jack Wong is the Chief Executive Officer and Chairman of the Company. By Waiver and Consent of Shareholders, Mr. Wong was elected to the board of directors of the Company, effective March 30, 2024. This represents sale of the property located at 1138 Wildhorse Parkway Drive, Chesterfield, Missouri 63005 (“Property”) owned by Verde Renewables Inc (“VRI”), for a current market value of $857,500. A gain on disposal of $161,156 was recognized as a result of this transaction for the six months ended December 31, 2025.

(#2) SB Resorts Sdn Bhd and BOC are wholly owned subsidiaries of BOB (holding 13.0% of the Company’s issued and outstanding common stock as of December 31, 2025).

(#3) Mr Teo Zye Keun is a Director of The Wision Project Sdn Bhd, a subsidiary of the Company.

Apart from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the Company has no other significant or material related party transactions during the periods presented

NOTE 18 - CONCENTRATIONS OF RISK

The Company is exposed to the following concentrations of risk:

(a) Major customers and major vendors

For the six months ended December 31, 2025 and 2024, there was one (1) single customer in each period whose revenue exceeded 10% of the revenue in the segment of production and distribution of renewable commodities.

	Revenue
	December 31, 2025						December 31, 2024
	USD			%			USD		%

Customer A	$	-	$	-		%		125,120	$	98	%
Customer B	$	6,100			88	%		-	-		%

	Account Receivable
	December 31, 2025		June 30, 2025

Customer A	$	-	$	187,314
Customer B	$	3,875	$	-

There were no vendors which exceeded 10% of direct costs for the six months ended December 31, 2025.

F-31

Table of Contents

For the six months ended December 31, 2024, there was one (1) single vendor whose direct costs exceeded 10% of the cost of revenue in the segment of production and distribution of renewable commodities.

	Direct Costs
	December 31, 2025					December 31, 2024
	USD			%		USD		%

Vendor A	$	-	$	-	%	$	8,800		15	%

	Account Payable
	December 31, 2025		June 30, 2025

Vendor A	$	4,400	$	8,800

(b) Economic and political risk

The Company’s major operations are presently conducted in the United States and Malaysia with intended expansion into Mexico and Canada. Accordingly, the political, economic, and legal environments in the United States, Mexico, Canada and Malaysia, as well as the general state of respective economies may influence the Company’s business, financial condition, and results of operations.

Further, the escalation tensions in the Middle East, including the continuing Russian – Ukraine conflict and trade wars may impact the global economic situation, which indirectly may impact the Company’s operations.

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of losses for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of MYR converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

NOTE 19 - PENSION COSTS

The Company is required to make contribution to their employees under a government-mandated defined contribution pension scheme for its eligible full-times employees in Malaysia. The Company is required to contribute a specified percentage of the participants’ relevant income based on their ages and wages level. During the six months ended December 31, 2025, and 2024, $1,924 and $3,138 contributions were made accordingly.

F-32

Table of Contents

NOTE 20 - SHARES ISSUED TO NONEMPLOYEE, EMPLOYEE AND DIRECTOR

On December 15, 2022, the Company entered into a Services Agreement with Looi Pei See (the “Looi Pei See Agreement”) to engage her as a consultant to develop the retail markets for the Company’s products and services in Malaysia and Singapore. The Company will pay Looi Pei See by the issuance of 1,140,000 shares of the Company’s restricted common stock on or before December 31, 2022. The shares were issued on December 31, 2022, for service period from December 15, 2022, to December 14, 2025. The fair value of 1,140,000 shares was $228,000 which was calculated based on stock price of $ 0.20 per share on December 31, 2022 (date of final board approval and grant date) and is being amortized over the vesting period. During the period ended December 31, 2025, the Company charged $34,741 to selling, general and administrative expenses as consulting expenses.

On October 23, 2023, the Company, through its wholly-owned subsidiary VRI, entered into a Services Agreement (the “Fosnacht Agreement”) with Donald R. Fosnacht to engage him as National Certification and Extensive BCR (Biochar Carbon Removal) Implementation Specialist to develop and implement a comprehensive strategy to obtain national and regional certification and endorsement for carbon net-negative construction products with high biochar content, encompassing asphalt, concrete, and soil stabilization as designated in the Agreement. Under the Agreement, the Company will pay Donald R. Fosnacht by the issuance of 1,000,000 shares of the Company’s restricted common stock on or before January 31, 2024. The term of the Fosnacht Agreement will remain effective until December 31, 2025, and both parties may renew the agreement, or enter into a new agreement as may be mutually agreed on terms to be separately negotiated. The fair value of 1,000,000 shares was $134,000 which was calculated based on stock price of $ 0.134 per share on January 31, 2024 (date of final board approval and grant date) and is being amortized over the vesting period. During the period ended December 31, 2025, the Company charged $30,782 to selling, general and administrative expenses as consulting expenses.

On April 20, 2024, the Company entered into two Services Agreements (the “NIE Agreements”) with Dr. Nam Tran and Dr. Raymond Powell to engage them as National Implementation Experts for its wholly-owned subsidiary Verde Renewables to initiate connections with esteemed asphalt contractors, identify potential partners, explore potential collaborations through their extensive networks in the asphalt industry and recommend strategies to capitalize on emerging opportunities as designated in the NIE Agreements. Under the NIE Agreements, the Company will pay Dr. Nam Tran and Dr. Raymond Powell each by the issuance of 3,000,000 shares of the Company’s restricted shares of common stock in three tranches of 1,000,000 shares each on or before July 31, 2024, October 31, 2025, and October 31, 2026, respectively. The term of the NIE Agreements will remain effective until April 30, 2027, and both parties may renew their respective agreement, or enter into a new agreement as may be mutually agreed on terms to be separately negotiated. Pursuant to the respective addendum to NIE Agreements dated June 29, 2024, each tranche of shares to be issued is compensation for each service period of 12 months beginning from May 1, 2024, May 1, 2025, and May 1, 2026, respectively. The fair value of the first 1,000,000 shares was $360,000 each, calculated based on stock price of $0.36 per share on July 31, 2024 (date of final board approval and grant date), and is being amortized over the respective vesting period.

The second tranche of 1,000,000 shares was issued to Dr. Raymond Powell on July 1, 2025 (also representing date of final board approval and grant date) at the stock price as of that date of $0.095, for a total value of $95,000 and is being amortized over the vesting period of 12 months beginning from May 1, 2025.

The second tranche of 1,000,000 shares to Dr. Nam Tran was not yet issued as of December 31, 2025. Subsequently, on January 5, 2026, the Company issued 1,727,115 of the Company’s restricted Common Shares to Dr. Nam Tran, for the twelve-month service period from May 1, 2025, based on the 30-day VWAP of $0.0579 as of December 31, 2025. The Company agreed that as part of the compensation package in the Addendum to the Services Agreement with Dr. Nam Tran and the Board approval on January 5, 2026, the share issuance shall be based on a fixed dollar amount of $100,000 as set forth in the Addendum, with the number of shares calculated based on the applicable share price at the time of issuance. As of December 31, 2025, the cost for the second tranche was accrued for based on the fixed dollar amount of $100,000 per the Addendum, totaling $67,213 for the services rendered till December 31, 2025.

The Company also agreed that as part of the compensation package in the Addendums to the Service Agreements with Dr. Nam Tram and Dr. Raymond Powell, that the share issuance for the third tranche for the service period 1 May 2026 to 30 April 2027, shall be based on a fixed dollar amount of $100,000 each as set forth in the respective Addendums, with the number of shares calculated based on the applicable share price at the time of issuance, subject to Board approval.

During the six-month period ended December 31, 2025, the Company charged a total of $98,301 to selling, general and administrative expenses as consulting expenses in respect of Dr. Nam Tran and Dr. Raymond Powell.

On June 1, 2024, the Company entered into a multi-year Services Agreement (the “Ludwig Agreement”) with Dale Ludwig to engage him as Strategic Advisor for the Company and all its subsidiaries, to maintain and build strong relationships with policymakers at both state and federal levels, collaborate with Missouri Department of Transportation, build relationships with Missouri Asphalt Pavement Association (MAPA) members, collaborate with Missouri contractors to encourage the use of the Company's technologies, identify current biochar producers in Missouri and engage with the Missouri Department of Economic Development. Pursuant to the Ludwig Agreement, the Company agreed to issue a total of 2,000,000 restricted shares of the Company’s common stock to Dale Ludwig over three tranches of 700,000 shares on or before August 31, 2024, 700,000 shares on or before October 31, 2025, and 600,000 shares on or before October 31, 2026. Pursuant to the addendum to the Ludwig Agreement dated June 29, 2024, each tranche of shares to be issued is compensation for each service period beginning 11 months from June 1, 2024 and 12 months from May 1, 2025, and May 1, 2026, respectively. The fair value of the first 700,000 shares was $210,000, calculated based on stock price of $0.30 per share on August 8, 2024 (date of final board approval and grant date) and is being amortized over the vesting period. The second tranche of 700,000 shares to Dale Ludwig was not yet issued as of December 31, 2025. Subsequently, on January 5, 2026, the Company issued 1,727,115 of the Company’s restricted Common Shares to Dale Ludwig, for the twelve-month service period from May 1, 2025, based on the 30-day VWAP of $0.0579 as of December 31, 2025. The Company agreed that as part of the compensation package in the Addendum to the Service Agreement with Dale Ludwig and the Board approval on January 5, 2026, the share issuance for the second tranche shall be based on a fixed dollar amount of $100,000 as set forth in the Addendum, with the number of shares calculated based on the applicable share price at the time of issuance. As of December 31, 2025, the cost for the second tranche was accrued for based on the fixed dollar amount of $100,000 per the Addendum, totaling $67,213 for the services rendered till December 31, 2025. The Company also agreed that as part of the compensation package in the Addendum to the Service Agreement with Dale Ludwig, that the share issuance for the third tranche for the service period 1 May 2026 to 30 April 2027, shall be based on a fixed dollar amount of $60,000 as set forth in the Addendum, with the number of shares calculated based on the applicable share price at the time of issuance, subject to Board approval.

During the six-month period ended December 31, 2025, the Company charged $55,424 to selling, general and administrative expenses as consulting expenses.

F-33

Table of Contents

The Company agreed to issue 670,000 of the Company’s restricted shares of common stock to Eric Bava, Chief Operating Officer of the Company, as part of the compensation package in the Bava Employment Agreement upon completing each full year of service. The term of the Bava Employment Agreement will remain effective until September 30, 2027. On August 30, 2024, the Company issued 670,000 of the Company’s restricted shares of common stock to Eric Bava as part of the compensation package in the Bava Employment Agreement. The fair value of first 670,000 shares was $181,235 which was calculated based on stock price of $0.2705 per share on August 30, 2024 (date of final board approval and grant date ), and is being amortized over the requisite service period from October 1, 2023, to September 30, 2024. The fair value of the share compensation for his second and third year of service was $60,000 respectively pursuant to the Addendum dated August 29, 2025, $60,000 is being accrued for the requisite service period from October 1, 2024, to September 30, 2025, and $15,123 for the services rendered till December 31, 2025. Subsequently, based on the Board approval on January 5, 2026, the Company issued 1,036,269 of the Company’s restricted Common Shares to Eric Bava, for service period from October 1, 2025 to September 30, 2026, based on the 30-day VWAP of $0.0579 as of December 31, 2025. During the six-month period ended December 31, 2025, the Company charged a total of $30,246 to selling, general and administrative expenses as salary expenses.

On July 31, 2024, Verde Renewables a wholly owned subsidiary of the Company, entered into Service Agreement with Jeremy P. Concannon (Chief Growth Officer (“CGO”) of the Company) effective from August 1, 2024 (the “Concannon Services Agreement”). Pursuant to the Concannon Services Agreement, the Company agreed to issue a total of 4,050,000 restricted shares of the Company’s common stock to Jeremy P. Concannon over three tranches of 1,350,000 shares each on or before August 31, 2024, August 31, 2025, and August 31, 2026 respectively. The term of the Concannon Service Agreement will remain effective until September 30, 2027, and both parties may renew the agreement, or enter into a new agreement as may be mutually agreed on terms to be separately negotiated. Pursuant to the addendum to the Concannon Service Agreement dated September 27, 2024, each tranche of shares to be issued as compensation for each service period beginning 12 months from August 1, 2024, and 2025, and for 14 months from August 1, 2026, to September 30, 2027, respectively. The fair value of the first 1,350,000 shares was $365,175, calculated based on stock price of $0.2705 per share on August 30, 2024 (date of final board approval and grant date), and is being amortized over the requisite service period. The second tranche of 1,350,000 shares to Jeremy P. Concannon remains to be issued to date. As of December 31, 2025, $53,533 is accrued for the services rendered from August 1, 2025 until December 31, 2025 based on management’s best estimate of the fair value as of the reporting date. During the six-month period ended December 31, 2025, the Company charged $84,548 to selling, general and administrative expenses as salary expenses.

The Company agreed to issue 50,000 of the Company’s restricted shares of common stock to Hannah Bruehl, Executive Assistant to C-Suite Executives of the Company for service period from September 3, 2024 to September 2, 2025, as part of the compensation package in the Employment Agreement signed on September 3, 2024. On January 3, 2025, the Company issued 50,000 of the Company’s restricted shares of common stock to Hannah Bruehl. The fair value of 50,000 shares was $9,280 which was calculated based on stock price of $0.1856 per share on January 3, 2025 (date of final board approval and grant date), and is being amortized over the requisite service period from September 3, 2024 to September 2, 2025. On January 5, 2026, the Company issued 86,355 of the Company’s restricted Common Shares to Hannah Bruehl, for service period from September 3, 2025 to September 2, 2026, based on the 30-day VWAP of $0.0579 as of December 31, 2025. The Company agreed that as part of the compensation package in the Addendum to the Employment Agreement with Hannah Bruehl, the share issuance shall be based on a fixed dollar amount of $5,000 as set forth in the Agreement and the Board approval on January 5, 2026, with the number of shares calculated based on the applicable share price at the time of issuance. During the six-month period ended December 31, 2025, the Company charged $3,271 to selling, general and administrative expenses as salary expenses.

On November 29, 2024, the Company, through its wholly-owned subsidiary Verde Renewables, entered into a consulting services agreement (the “AUM Agreement”) to engage AUM Media Inc (“AUM”), a company incorporated in the State of Delaware, as a Capital Markets, Investor Relations and Media Relations Advisor to provide advice to the Company on its preparations for an equity raise and the planned uplisting to NASDAQ. Pursuant to terms of the AUM Agreement, the services will be provided by AUM on an annual contract basis and the agreement will continue for 12 months, starting January 1, 2025 to December 31, 2025, unless it is terminated in accordance with the termination terms under the AUM Agreement. VRI agreed to pay a fixed monthly discounted fee of $6,000 per month, payable in advance on the first day of each month. In addition, the Company shall issue shares equivalent to 9,313,100 shares of the Company’s restricted common stock to AUM or any affiliate to be designated by AUM, which represents 0.75% of the Company’s total shares outstanding as of November 29, 2024. The share issuance will occur as follows: 4,656,550 shares of the Company’s restricted common stock, being 50% of the 0.75% of the Company’s total shares outstanding, to be issued upon the signing of the Agreement, with the remaining 4,656,550 shares to be issued within three days following the Company's listing on the NASDAQ. Subsequently on January 2, 2025, the Company issued the first 4,656,550 of the Company’s restricted shares of common stock to Aegis Ventures Limited as designated by AUM. The fair value of the first tranche of 4,656,550 shares was $745,048 calculated based on stock price of $0.16 per share on November 29, 2024 (grant date) and is being amortized over the service period of 12 months commencing January 2025. During the six-month period ended December 31, 2025, the Company charged $375,586 to selling, general and administrative expenses as consulting expenses.

The Company agreed to issue 350,000 of the Company’s restricted shares of common stock to Karl Strahl, a Director of the Company for service period from May 1, 2025 to April 30, 2026, as part of the compensation package in the Director Appointment Agreement that the Company entered into with Karl Strahl on May 1, 2025. On June 1, 2025, the Company issued 350,000 of the Company’s restricted shares of common stock to Karl Strahl. The fair value of 350,000 shares was $33,110 which was calculated based on stock price of $0.0946 per share on June 1, 2025 (date of final board approval and grant date), and is being amortized over the requisite service period from May 1, 2025 to April 30, 2026. During the six-month period ended December 31, 2025, the Company charged $16,691 to selling, general and administrative expenses as Director’s fee.

F-34

Table of Contents

On October 18, 2024, the Company entered into a binding Term Sheet with C-Twelve Pty Ltd (“C-Twelve”), a corporation incorporated in Western Australia, granting the Company (i) an exclusive license to utilize its proprietary binder and biochar asphalt mixed designs (the “Licensed Technology”) for the production and commercialization of asphalt surfacing-related products (the “End Products”) within the United States of America and (ii) the first right of refusal to extend the exclusive licensing of the Licensed Technology to other countries and territories subject to terms and conditions to be mutually agreed upon. The Company shall commit to producing a minimum quantity of End Products each year, as defined in the definitive agreement (the “Minimum Production Amount”). The specific Minimum Production Amount will be stipulated in an appendix or exhibit to the final licensing agreement. The Company shall pay C-Twelve royalties based on the Minimum Production Amount, at a rate mutually agreed upon by both parties and specified in the definitive agreement. Should the Company fail to meet the Minimum Production Amount in any given year, it shall remain obligated to pay royalties based on the agreed upon minimum production levels. In the event that production exceeds the Minimum Production Amount, additional royalties shall be payable for the excess production, calculated at the same royalty rate or as otherwise mutually agreed in the definitive agreement. Both parties will mutually agree on a Carbon Credit percentage allowance for C-Twelve. C-Twelve shall grant the Company the right to file, prosecute, and maintain United States patent applications incorporating C-Twelve’s Intellectual Property (IP), subject to C-Twelve’s final review and approval before submission. All such patents will be filed and maintained under the Verde brand name. The Company shall reserve the right to market and sell End Products under its own brand names, with C-Twelve being referenced, as well as C-Twelve having the right to market the Company’s activities under the definitive agreement. C-Twelve shall also collaborate with the Company on a joint installation of its proprietary technology that will take place on the Company’s designated cross-section at the NCAT Test Track in Opelika, Alabama, with a target completion between December 16–20, 2024. The term sheet, originally set to expire on February 28, 2025, has been extended until May 31, 2025. Subsequently the definitive agreement, namely the C-Twelve Agreement, was entered into between the Company and C-Twelve on May 19, 2025 (“Effective Date”). The Company agreed to issue 1,500,000 shares of the Company’s restricted common stock to C-Twelve within thirty (30) business days after the Effective Date. On June 1, 2025, the Company issued 1,500,000 shares of the Company’s restricted common stock to Sundeo Pty Ltd, an affiliate designated by C-Twelve, pursuant to the C-Twelve Agreement. The fair value of 1,500,000 shares was $141,900 which was calculated based on stock price of $0.0946 per share on June 1, 2025 (date of final board approval and grant date), and is being amortized over the license period of 10 years from May 19, 2025 to May 18, 2035. During the six-month period ended December 31, 2025, the Company charged $7,149 to selling, general and administrative expenses as licensing fee.

A summary of the status of the Company’s non-vested shares as of December 31, 2025 and June 30, 2025, and changes during the six months ended December 31, 2025 and the year ended June 30, 2025, is presented below:

	December 31, 2025					June 30, 2025
Non-vested shares	Shares			Weighted-Average-Grant Date Fair Value		Shares			Weighted-Average-Grant Date Fair Value

Nonemployee
At beginning of the year		4,233,167		$	0.137		1,229,508		$	0.163
Granted		1,000,000			0.095		8,856,550			0.205
Vested		(3,497,638	)		0.146		(5,852,891	)		0.245
At the end of the year		1,735,529		$	0.095		4,233,167		$	0.137

Employee and director
At beginning of the year		414,932		$	0.145		-		$	-
Granted		-			-		2,420,000			0.243
Vested		(299,863	)		0.164		(2,005,068	)		0.264
At the end of the year		115,069		$	0.095		414,932		$	0.145

As of December 31, 2025 and June 30,2025, the total stock-based compensation for nonemployees related to non-vested awards not yet recognized is $164,313 and $581,338, and this is expected to be recognized over a weighted-average period of 7.67 and 3.79 years respectively.

As of December 31, 2025 and June 30, 2025, the total stock-based compensation for employees and directors related to non-vested awards not yet recognized is $10,886 and $60,219, and this is expected to be recognized over a weighted-average period of 0.33 and 0.60 years respectively.

There was no income tax benefit recognized associated with the share-based compensation expenses.

F-35

Table of Contents

NOTE 21 - COMMITMENTS AND CONTINGENCIES

Future commitments with regards to repayment of lease liabilities are disclosed in Note 12.

Apart from the above, as of December 31, 2025, the Company had the following capital commitment:

a) commitment to issue restricted shares of common stock to the following service providers on or before October 31, 2025 and 2026, subject to final board approval for the second and third tranches equivalent to the fixed dollar amounts as below, for services to be performed pursuant to the Service Agreements and Addendums signed with nonemployees as disclosed in Note 20:

Financial year ended June 30, 2026
Nam Tran			100,000
Dale Ludwig			100,000
			200,000

Financial year ended June 30, 2027:
Nam Tran			100,000
Raymond Powell			100,000
Dale Ludwig			60,000
			260,000

b) commitment to issue 1,350,000 of the Company’s restricted shares of common stock to employee, Jeremy P. Concannon for the second tranche for a twelve-month service period from 1 August 2025 which was due on or before August 31, 2025 and the third tranche of 1,350,000 restricted shares of common for a fourteen-month period commencing August 1, 2026, both being subject to final board approval and pursuant to the Service Agreement signed as disclosed in Note 20.

c) commitment to issue restricted shares of common stock equivalent to $60,000 subject to final board approval, to Eric Bava pursuant to an addendum to his Employment Agreement dated August 29, 2025 for the requisite service period from October 1, 2024, to September 30, 2025 and for the requisite service period from October 1, 2025, to September 30, 2026 as disclosed in Note 20.

d) commitment to cancel 375,000 restricted common shares pursuant to the Service Agreement signed and Service and Stock Cancellation Agreement with EMGTA LLC as disclosed in Note 14.

e) quarterly committed payments of $62,500, to be paid in advance for period from January 2026 to December 2026 to support a 3-year Performance Testing Project titled “Structural Capacity of Sustainable Pavement” pursuant to an agreement entered with NCAT at Auburn University on June 27, 2024.

f) commitment to issue 4,656,550 restricted shares of common stock to Aegis Ventures Limited pursuant to the terms of the consulting services agreement that the Company through its wholly-owned subsidiary Verde Renewables entered into with AUM on November 29, 2024, within three days following the Company’s listing on the NASDAQ.

g) commitment pursuant to the terms of the C-Twelve Agreement dated May 19, 2025 and its’ addendum dated October 8, 2025 entered into by the Company’s wholly-owned subsidiary, Verde Renewables, with C-Twelve, (i) to allocate to C-Twelve a royalty equal to three percent (3%) of all future carbon removal credits generated through the use of Verde-C-Twelve intellectual properties, (ii) to pay an additional license fee of $1,000,000 for the expanded territories of Mexico and Canada, and (iii) to provide a loan to C-Twelve in an amount not less than $2,000,000 (the “C-Twelve Loan”), with interest accruing at the lowest applicable federal rate, within thirty (30) days of our Common Stock being successfully listed on a U.S. national exchange, provided that if such funding is not achieved by July 31, 2026, C-Twelve shall have the right, on ten (10) business days’ notice, to hold us in breach of the Joint Development Agreement.

h) commitment to issue 86,355 restricted shares of common stock to employee, Hannah Bruehl, for service period from September 3, 2025 to September 2, 2026, based on the 30-day VWAP of $0.0579 as of December 31, 2025.

i) commitment to provide Ergon with forty percent (40%) of its share of the carbon removal credits generated from the mixing of the final carbon sequestering BioAsphalt™ surface material, so long as the carbon removal credits are generated from bulk mixing or packaged mixed product, and the mixing of the final BioAsphalt™ surface material includes biochar purchased from the Company.

As of December 31, 2025, the Company has no material contingencies.

F-36

Table of Contents

NOTE 22 - SUBSEQUENT EVENTS

On January 5, 2026, the Company issued 1,727,115 of the Company’s restricted Common Shares to Nam Tran, Consultant of the Company for service period from May 1, 2025, and May 1, 2026, based on the 30-day VWAP of $0.0579 as of December 31, 2025. The Company agreed that as part of the compensation package in the Addendum to the Services Agreement with Nam Tran, the share issuance shall be based on a fixed dollar amount of $100,000 as set forth in the Agreement, with the number of shares calculated based on the applicable share price at the time of issuance.

On January 5, 2026, the Company issued 1,727,115 of the Company’s restricted Common Shares to Dale Ludwig, Strategic Advisor of the Company for service period from May 1, 2025, and May 1, 2026, based on the 30-day VWAP of $0.0579 as of December 31, 2025. The Company agreed that as part of the compensation package in the Addendum to the Services Agreement with Dale Ludwig, the share issuance shall be based on a fixed dollar amount of $100,000 as set forth in the Agreement, with the number of shares calculated based on the applicable share price at the time of issuance.

On January 5, 2026, the Company issued 1,036,269 of the Company’s restricted Common Shares to Eric Bava, Chief Operating Officer of the Company for service period from October 1, 2025 to September 30, 2026, based on the 30-day VWAP of $0.0579 as of December 31, 2025. The Company agreed that as part of the compensation package in the Addendum to the Employment Agreement with Eric Bava, the share issuance shall be based on a fixed dollar amount of $60,000 as set forth in the Agreement, with the number of shares calculated based on the applicable share price at the time of issuance.

On January 5, 2026, the Company issued 86,355 of the Company’s restricted Common Shares to Hannah Bruehl, Chief of Staff of the Company for service period from September 3, 2025 to September 2, 2026, based on the 30-day VWAP of $0.0579 as of December 31, 2025. The Company agreed that as part of the compensation package in the Addendum to the Employment Agreement with Hannah Bruehl, the share issuance shall be based on a fixed dollar amount of $5,000 as set forth in the Agreement, with the number of shares calculated based on the applicable share price at the time of issuance.

On February 10, 2026, the Company received its first two purchase orders from Ergon for the Company’s proprietary cold mix biochar asphalt emulsifying agent, Verde V24, with delivery scheduled within the quarter ending March 31, 2026. The gross revenue to be generated from these purchase orders is expected to be $460,000. This material event represents the Company’s first commercial transaction following the execution of its 10-year exclusive licensing agreement with Ergon in October 2025 and is the first step in the Company and Ergon’s combined go to market strategy for our cold mix BioAsphalt^TM in North America.

On December 23, 2025, the Company filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission to register an up to $5.75 million firm commitment underwritten public offering and concurrent uplisting of the Company’s Common Shares from the OTCQB Market to the Nasdaq Capital Market (the “Uplisting”). The Uplisting will require the Company’s board of directors to approve a reverse stock split of the Common Shares in order to meet the listing requirements of the Nasdaq Capital Market. The consummation of the Uplist will trigger payments to C-Twelve of $3,000,000 as described elsewhere in these footnotes.

In accordance with ASC Topic 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before unaudited condensed consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2025, up through the date the Company issued the unaudited condensed consolidated financial statements.

NOTE 23 – RE-PRESENTATION

Certain prior year amounts have been re-presented to conform to the current year’s presentation. The re-presentation had no impact on previously reported income or losses.

F-37

Table of Contents

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read together with our unaudited condensed financial statements and the related notes appearing elsewhere in this Quarterly Report. See “Cautionary Note Regarding Forward-Looking Statements.” Actual results could differ materially from those discussed below.

Overview

We are a road construction and building materials company offering proprietary, environmentally sustainable materials and seeking to redefine our industry with a clear mission: enabling the #TransitiontoZero™. Our proprietary product BioAsphalt™ incorporates biochar, a powerful carbon sequestering material, into infrastructure with the goal of reducing emissions, improving performance, and lowering overall costs. We also offer a licensed proprietary cold mix biochar asphalt emulsifying agent, which we call “Verde V24”. Further, we expect to generate revenues from the generation by our products, and our subsequent sale, of carbon removal credits. We believe our proprietary products, know-how and business plan place us at the forefront of sustainable innovation in the construction and building materials sector, an industry we believe is long overdue for transformation.

Our strategic roadmap for achieving net-zero emissions—what we call the Verde Net Zero Blueprint—has achieved the following significant milestones:

	●	The issuance to our company in April 2025 of the world’s first carbon removal credit from asphalt production and application, certified by Puro.earth, the leading global registry for engineered carbon removal.

	●	Technological validation of our BioAsphalt™ by NCAT, including receipt of preliminary performance results from NCAT in July 2025 that demonstrated consistent durability, particularly under low-volume roadway conditions. Most recently, in September 2025, NCAT’s latest evaluation of our cold recycling mix using 100% reclaimed asphalt pavement (“RAP”) from laboratory testing demonstrated that our cold-recycled mix not only meets but exceeds industry specifications for cold-recycled asphalt. These results showed superior cohesion, high tensile strength ratio (“TSR”), and retained stability compared to standard cold mix benchmarks, validating its strength, durability, and moisture resistance.

Our Verde Net Zero Blueprint is comprised of our portfolio of validated technologies that enable the production of sustainable infrastructure materials with the integrated ability to generate certified carbon removal credits. This positions carbon sequestration not just as an environmental co-benefit, but as a monetizable feature embedded in our business plan.

As the rise of artificial intelligence accelerates data center energy consumption, which is now projected to account for a growing share of global electricity use, enterprises worldwide are facing increasing pressure to offset their carbon footprints. This is driving up demand for high-integrity, verifiable carbon credits.

Our model presents a novel combination of infrastructure performance with measurable climate impact, establishing us as a first mover in scalable Net Zero solutions, which we believe positions us well to meet the demands of a rapidly decarbonizing, carbon-constrained economy.

Table of Contents

With key third-party validations from groups such as NCAT and Puro. earth in place, we are now focused on commercializing our solutions in the United States, our most strategic market. To this end, we recently entered into an exclusive licensing agreement with Ergon, an industry leader in asphalt innovation and supply and one of the largest liquid asphalt and emulsion marketers in North America, for the production of asphalt surface course material containing our proprietary solution across North America. As our domestic operations scale through Ergon, we plan to license the Verde Net Zero Blueprint globally, targeting infrastructure and materials companies in countries aligned with the Paris Climate Agreement and pursuing Net Zero by 2050.

We plan to expand operations and generate and grow revenue over the next twelve (12) months primarily through marketing and selling our proprietary road technologies through Ergon exclusively in North America, with an initial focus on the United States. Production planning of our materials has already commenced, with distribution anticipated to occur through the Ergon’s established sales channels, reaching asphalt mixing plants across the United States, Canada and Mexico for blending and placement. Embedding our technology into Ergon’s nationwide business footprint would enable immediate scalability and near-term revenue generation.

We believe our asset light business model enables scalable growth while minimizing capital intensity, creating recurring revenue streams through licensing, sales, royalties, carbon monetization, and strategic partnerships. We operate through our primary U.S. subsidiary, Verde Renewables, headquartered in St. Louis, Missouri.

Recent Developments

Ergon Purchase Orders

On February 10, 2026, we received the first two purchase orders from Ergon for our proprietary cold mix biochar asphalt emulsifying agent, Verde V24, with delivery scheduled within the quarter ending March 31, 2026. The revenue to be generated from these purchase orders is expected to be approximately $460,000. These purchase orders represent our first commercial transaction following the execution of our 10-year exclusive licensing agreement with Ergon in October 2025 and is the first step in our and Ergon’s combined go to market strategy for our cold mix BioAsphalt^TM in North America.

Key Factors that Affect Our Results of Operations

We believe the following key factors may affect our financial condition and results of operations:

	●	Ergon License: Our entry into the Ergon License is expected to drive long-term revenue growth through product sales of Verde V24 and related proprietary materials. The Ergon License establishes Ergon as the exclusive licensee for Verde V24 in the United States, Canada and Mexico, enabling large-scale commercialization of our Verde V24 technology while allowing us to expand our business without the capital demands of direct manufacturing or distribution.

	●	Adoption of Biochar-Asphalt Technology: Market acceptance of the Verde Net Zero Blueprint technologies by contractors, state Departments of Transportation, and private sector customers will influence royalty streams and future expansion opportunities.

	●	Carbon Credit Monetization: The issuance, pricing, and sales of certified carbon removal credits tied to our biochar-based asphalt applications will be a key driver of financial performance.

	●	Operational and Integration Costs: Expenses related to technology transfer, compliance monitoring, and integration into licensee production systems will impact near-term margins.

	●	Regulatory and Environmental Policies: Federal and state infrastructure spending, emissions reduction mandates, and climate policies may accelerate the adoption of our technology and corresponding revenue growth.

	●	Continuous Improvement and Innovation: We are committed to continuous improvement and innovation on our core technologies to enhance performance, durability, and environmental benefits.

	●	Maintaining the Quality of our Products: We seek to maintain robust quality assurance and measurement systems to confirm that all licensed products consistently meet our technical specifications and industry standards.

Table of Contents

Results of Operations

For the three months ended December 31, 2025 and 2024:

The following table sets forth selected financial information from our statements of comprehensive loss for the three months ended December 31, 2025 and 2024:

	December 31, 2025			December 31, 2024			Change
	Amount			Amount			%
	(Unaudited)			(Unaudited)
Revenue	$	4,679		$	2,423			93.1	%
Cost of revenue	$	(886	)	$	(9,552	)		-90.7	%
Gross profit (loss)	$	3,793		$	(7,129	)		-153.2	%
Selling, general and administrative expenses	$	(1,126,428	)	$	(2,383,949	)		-52.7	%
Other operating expenses	$	(57,241	)	$	(50,698	)		12.9	%
Loss from operation	$	(1,179,876	)	$	(2,441,776	)		-51.7	%
Interest expense	$	-		$	(5,895	)		-100.0	%
Other income (expense)	$	245,800		$	(246,658	)		-199.7	%
NET LOSS	$	(934,076	)		(2,694,329	)		-65.3	%

The average rate of MYR : USD for three months ended December 31, 2025 and December 31, 2024 was 0.2424 and 0.2257, respectively.

Revenue

We generated $4,679 in revenue for the three months ended December 31, 2025, representing an increase of $2,256, or 93.1%, compared to revenue of $2,423 in the prior period. Our revenue for the three months ended December 31, 2025 was mainly derived from the sale of our 50-lb bagged BioAsphalt™ product. In contrast, revenue for the three months ended December 31, 2024 was mainly derived from income from event management.

The sales in current period primarily reflects our planned depletion of our initial formulation of our bagged BioAsphalt™ product as we shifted toward an upgraded formulation of our BioAsphalt™ product that includes, among other enhancements, the use of recycled asphalt materials, an improved designer blend of biochar, and a more compatible grade of liquid asphalt in the emulsion. The increase in revenue for the three months ended December 31, 2025, compared to the same period in 2024, was primarily attributable to the Company’s intended depletion of the bagged BioAsphalt™ in preparation for the execution of its commercialization strategy for its proprietary BioAsphalt™ product and its continued focus on expanding core revenue-generating activities.

Cost of revenue

Cost of revenue in the three months ended December 31, 2025 and December 31, 2024 were $886 and $9,552, respectively, a decrease of $8,666 or 90.7%. The high cost in the previous period was mainly due to additional packaging costs incurred on goods previously sold. The absence of the non-recurring packaging costs incurred in the prior-year period and a favorable shift toward sales of its bagged BioAsphalt^TM product resulted in the decreased cost in the current period.

Gross Profit

Gross profit of $3,793 was recorded for the three months ended December 31, 2025, compared to a gross loss of $7,129 for the corresponding period in 2024, representing an increase in profit of $10,922 or 153.2%. Gross loss was generated for the three months ended December 31, 2024 as opposed to a gross profit for the three months ended December 31, 2025 mainly due to the nonrecurring packaging costs incurred on goods previously sold, and a favorable shift toward sales of bagged BioAsphalt™ as mentioned above.

Selling, General and Administrative Expenses

Selling, general and administrative expenses was comprised mainly of salaries, office costs, legal and professional fees, consultancy fee, research and development cost and travelling expenses. We incurred $1,126,428 and $2,383,949 in selling, general and administrative expenses for the three months ended December 31, 2025 and 2024, respectively. Selling, general and administrative expenses decreased by 52.7%, or $1,257,521, primarily due to the absence of the special bonus of $1.25 million to CEO Jack Wong in recognition of his leadership, strategic vision and outstanding contributions in transforming the Company into a pioneer in the Net Zero building materials and carbon removal industry recorded in the prior period.

Table of Contents

Other Operating Expenses

Total other operating expenses for the period ended December 31, 2025 was $57,241, an increase of $6,543, or 12.9%, compared to $50,698 for the period ended December 31 2024. Other operating expenses were comprised of expenditure related to the maintenance of our biofraction plant in Borneo, arising from our strategic decision to temporarily cease its operation in June 2023 to focus on our North American operations.

Interest expense

Total interest expense for the period ended December 31, 2025 was $0, compared to $5,895 for the period ended December 31, 2024. The absence of interest expense during the current period was primarily attributable to the settlement of lease liabilities in our prior fiscal year in connection with the disposal of asset held for sale and certain property, plant, and equipment that were under financing arrangements.

Other income (expense)

Other income for the period ended December 31, 2025 was $245,800, an increase of $492,458, or 199.7%, compared to other expense, net of $246,658 for the period ended December 31, 2024. Other expenses, net of $246,658 for the three months ended December 31, 2024, mainly consists of gain on disposal of property, plant and equipment of $161,156, interest income from placement of deposit with bank of $16,271 and offset by reversal of unrealized foreign exchange gain of $442,021 due to lower fluctuations of the U.S. dollar against the Malaysian Ringgit. Other income of $245,800 for the three months ended December 31, 2025, mainly consist of unrealized foreign exchange gain of $234,395, interest income from placement of deposit with bank of $4,779 and sundry income of $6,626. Interest income from bank deposits declined to $4,779 in the three months ended December 31, 2025 from $16,271 in the three months ended December 31, 2024, reflecting reduced deposit placements in this period.

Net loss

As a result of the above factors, we incurred a net loss of $934,076 for the three months ended December 31, 2025, representing a decrease in net loss of $1,760,253, or 65.3%, compared to a net loss of $2,694,329 for the three months ended December 31, 2024.

For the six months ended December 31, 2025 and 2024:

The following table sets forth selected financial information from our statements of comprehensive loss for the three months ended September 30, 2025 and 2024:

	December 31, 2025			December 31, 2024			Change
	Amount			Amount			%
	(Unaudited)			(Unaudited)
Revenue	$	6,948		$	127,993			-94.6	%
Cost of revenue	$	(2,221	)	$	(59,148	)		-96.2	%
Gross profit	$	4,727		$	68,845			-93.1	%
Selling, general and administrative expenses	$	(2,015,404	)	$	(3,198,878	)		-37.0	%
Other operating expenses	$	(113,137	)	$	(105,816	)		6.9	%
Loss from operation	$	(2,123,814	)	$	(3,235,849	)		-34.4	%
Interest expense	$	-		$	(101,360	)		-100.0	%
Other income	$	270,183		$	997,595			-72.9	%
NET LOSS	$	(1,853,631	)		(2,339,614	)		-20.8	%

The average rate of MYR : USD for six months ended December 31, 2025 and December 31, 2024 was 0.2395 and 0.2281, respectively.

Revenue

We generated $6,948 in revenue for the period ended December 31, 2025, representing a decrease of $121,045, or 94.6%, compared to revenue of $127,993 in the prior period. Our revenue was mainly derived from the sale of our 50-lb bagged BioAsphalt™ product.

The decrease in sales primarily reflects our planned depletion of our initial formulation of our bagged BioAsphalt™ product as we shifted toward an upgraded formulation of our BioAsphalt™ product that includes, among other enhancements, the use of recycled asphalt materials, an improved designer blend of biochar, and a more compatible grade of liquid asphalt in the emulsion. During this transition period, production and distribution of the earlier formulation were intentionally scaled back to support ongoing research and development activities. The transition from the bagged BioAsphalt™ to the upgraded formulation has caused a temporary dip in revenue until the upgraded formulation’s full launch and integration into our commercial channels.

Table of Contents

Cost of revenue

Cost of revenue in the six months ended December 31, 2025 and December 31, 2024 were $2,221 and $59,148, respectively, a decrease of $56,927 or 96.2%. The decrease is mainly due to the decreased volume of sales as mentioned above.

Gross Profit

Gross profit of $4,727 was recorded for the six months ended December 31, 2025, compared to a gross profit of $68,845 for the corresponding period in 2024, representing a decrease of $64,118 or 93.1%. The decline was primarily driven by the significantly lower quantity of product sold during the current period. In addition, sales in the current period were made largely at the distribution level, which typically generate lower margins than retail-level sales, which predominated during the corresponding period in 2024.

Selling, General and Administrative Expenses

Selling, general and administrative expenses was comprised mainly of salaries, office costs, legal and professional fees, consultancy fee, research and development cost and travelling expenses. Selling, general and administrative expenses were $2,015,404 and $3,198,878 for the six months ended December 31, 2025 and 2024, respectively. The $1,183,474, or 37.0% decrease was primarily due to the absence of the special bonus of $1.25 million to CEO Jack Wong in recognition of his leadership, strategic vision and outstanding contributions in transforming the Company into a pioneer in the Net Zero building materials and carbon removal industry recorded in the prior period, partially offset by an increase in legal and professional fees on the Ergon License of $150,000 and research and development costs of $125,000 in current period as we continued our work to the upgraded formulation of our BioAsphalt™ product.

Other Operating Expenses

Total other operating expenses for the period ended December 31, 2025 was $113,137, an increase of $7,321, or 6.9%, compared to $105,816 for the period ended December 31 2024. Other operating expenses were comprised of expenditure related to the maintenance of our biofraction plant in Borneo, arising from our strategic decision to temporarily cease its operation in June 2023 to focus on our North American operations.

Interest expense

Total interest expense for the period ended December 31, 2025 was $0, compared to $101,360 for the period ended December 31, 2024. The absence of interest expense during the current period was primarily attributable to the settlement of lease liabilities in our prior fiscal year in connection with the disposal of asset held for sale and certain property, plant, and equipment that were under financing arrangements, and the early conversion of promissory notes with an aggregate principal amount of $675,888 on August 16, 2024 in the prior period.

Other income

Other income for the period ended December 31, 2025 was $270,183, a decrease of $727,412, or 72.9%, compared to $997,595 for the period ended December 31, 2024. The decrease was primarily due to the absence of a non-recurring insurance claim gain of $481,513 and gain on disposal of property, plant and equipment of $161,156 recognized in the six months ended December 31, 2024. Interest income from bank deposits declined to $11,823 in the six months ended December 31, 2025 from $38,809 in the six months ended December 31, 2024, reflecting reduced deposit placements in this period. Unrealized foreign exchange gain decreased to $251,734 in the six months ended December 31, 2025 from $276,680 in the six months ended December 31, 2024.

Net loss

As a result of the above factors, we incurred a net loss of $1,853,631 for the six months ended December 31, 2025, representing a decrease in net loss of $485,983, or 20.8%, compared to a net loss of $2,339,614 for the six months ended December 31, 2024.

Table of Contents

Liquidity and Capital Resources

The following summarizes the key component of our cash flows for the six months ended December 31, 2025 and 2024.

Cash Flow Date	December 31, 2025			December 31, 2024

Net Cash Used in operating activities	$	(1,717,203	)	$	(1,008,400	)
Net Cash Provided by investing activities		276,484			1,384,163
Net Cash Provided by financing activities		2,448,000			244,526
Effect of exchange rate fluctuation on cash and cash equivalents		(2,539	)		(7,426	)
Net increase in cash and cash equivalents		1,004,742			612,863
Cash and cash equivalents, beginning of period		1,021,112			279,137
Cash and cash equivalents, ending of period	$	2,025,854		$	892,000

Net Cash Used in Operating Activities

Cash used in operating activities reflects net loss adjusted for certain non-cash items, including depreciation expense, amortization of right of use assets and stock-based compensation, and the effects of changes in operating assets and liabilities. Our net cash used in operating activities increased $708,803, or 70.3%, from $1,008,400 for period ended December 31, 2024, to $1,717,203 for period ended December 31, 2025. The increase in cash used in operating activities for the period ended December 31, 2025, as compared to the same period in 2024 was primarily due to operational loss of $1,853,631 offset by noncash movements of $676,517 and net decrease in working capital of $540,089. The noncash expenses comprised $111,676 in depreciation, $51,429 in amortization, $601,983 in share-based compensation to nonemployee, $118,065 in share-based compensation to employees, $16,691 in share-based compensation to a director, operating lease expense of $28,407 and offset by unrealized foreign exchange gain of $251,734. The net decrease in working capital was used in amount due to director, account payables, prepayments, repayments on leases, accrued liabilities and other payables, offset against increase of working capital from inventories, related parties and other receivables and deposits.

Net Cash Provided by Investing Activities

The net cash provided by investing activities for the period ended December 31, 2025 was $276,484, representing a decrease of $1,107,679, or 80%, compared to net cash from investing activities of $1,384,163 for the period ended December 31, 2024. The net cash provided by investing activities of $276,484 for the six months ended December 31, 2025 was primarily attributable to the withdrawal of $500,000 from a matured certificate of deposit to support general working capital and operating activities, partially offset by a separate deposit into a certificate of deposit with the bank of $223,516. Meanwhile, during the period ended December 31, 2024, the net cash provided by investing activities of $1,384,163 was due to proceeds from disposal of assets held for sale of $593,300, proceeds from insurance recoveries of $541,221, the purchase of property, plant and equipment of $358, and withdrawal from a matured certificate of deposit in the bank of $250,000 to support general working capital and operating activities.

Net Cash Provided by Financing Activities

The net cash provided by financing activities for the six months ended December 31, 2025, was $2,448,000, representing an increase of $2,203,474, or 901.1%, compared to the net cash provided by financing activities for the six months ended December 31, 2024, of $244,526. The net cash provided by financing activities of $2,448,000 for the six months ended December 31, 2025, was primarily attributable to proceeds from common stock issuance, including $2,000,000 from Ergon. Meanwhile, for the period ended December 31, 2024, the net cash provided by financing activities of $244,526 resulted from proceeds from common stock issuance and common stock to be issued through private placements of $904,000, set off by repayment to lease liabilities of $614,474 and a refund from the cancellation of common stock of $45,000.

We generated a net cash inflow of $1,004,742 for the period ended December 31, 2025.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make judgments, assumptions, and estimates that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes thereto. Note 2, entitled “Summary of Significant Accounting Policies,” to the unaudited condensed consolidated financial statements describes the significant accounting policies and methods used in the preparation of the unaudited condensed consolidated financial statements. The accounting policies described below are significantly affected by critical accounting estimates. Such accounting policies require significant judgments, assumptions, and estimates used in the preparation of the unaudited condensed consolidated financial statements, and actual results could differ materially from the amounts reported based on these policies.

Table of Contents

1. Useful Lives and Depreciation of Property, Plant and Equipment

Our property, plant and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. We depreciate our property, plant and equipment on a straight-line basis over their estimated useful lives, which range from 5 to 10 years for plant and machinery, and 3 to 10 years for other asset categories, including office equipment, computers, motor vehicles, furniture and fittings, and renovations. The depreciation method and estimated useful lives reflect management’s judgment based on historical experience, the nature of the assets, their anticipated use, and technological and economic factors.

The estimation of useful lives is a critical accounting estimate because it requires significant management judgment and has a material impact on our consolidated financial statements. Changes in the estimated useful lives of our assets could significantly affect the timing of depreciation expense recognized in future periods. For the six months ended December 31, 2025 and 2024, depreciation expense totaled $111,676 and $137,375, respectively.

We periodically review the estimated useful lives of our assets and revise them when events or changes in circumstances indicate that the current estimates are no longer appropriate. We also review our assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

2. Impairment of Long-Lived Assets and Intangible Assets

We assess long-lived assets, including property, plant and equipment, and indefinite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of long-lived assets is measured by comparing the carrying value to the estimated undiscounted future cash flows expected from the asset or asset group.

If the carrying value exceeds the expected undiscounted cash flows, the impairment loss is measured as the excess of the carrying amount over the fair value, which is generally determined using discounted cash flow models involving significant estimates and assumptions, such as future revenues, operating margins, and discount rates.

These estimates are inherently subjective and sensitive to changes in assumptions. Changes in these assumptions or actual results that differ from those used in our estimates could result in material impairment charges in future periods.

No plant and machinery were impaired and written off during the six months ended December 31, 2025 and 2024 respectively.

3. Allowance for Expected Credit Losses

We maintain an allowance for expected credit losses on accounts receivable and other financial instruments based on a current expected credit loss (CECL) model under ASC 326. The allowance is estimated using a combination of quantitative and qualitative factors, including historical loss experience, current economic conditions, customer-specific credit risk, and reasonable and supportable forecasts of future conditions.

Significant judgment is involved in identifying relevant risk factors, evaluating the impact of macroeconomic variables (e.g., inflation, interest rates, geopolitical instability), and determining the appropriate loss rates. A change in these factors could materially affect the timing and amount of credit loss provisions.

No allowance for expected credit losses on accounts receivable during the six months ended December 31, 2025 and 2024 respectively.

4. Revenue Recognition and Principal vs. Agent Determination

We recognize revenue in accordance with ASC 606 by identifying performance obligations in contracts, determining the transaction price, and allocating the price to each performance obligation. Significant estimates and judgments are involved in determining the point in time when control of a product transfers to the customer and whether we act as principal or agent in arrangements involving third-party contributions to the delivery of goods.

These judgments affect the timing and amount of revenue recognized. Factors considered include our role in the transaction, control of inventory before transfer, and pricing discretion. Incorrect judgments could materially impact reported revenue and profitability.

Table of Contents

5. Stock-Based Compensation

We account for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718-10, Compensation—Stock Compensation, which requires all share-based payment arrangements with employees, directors, and nonemployees to be measured and recognized in the financial statements based on the fair value of the equity instruments granted

We consider the accounting for stock-based compensation to be a critical accounting estimate due to the significant judgment and assumptions involved in determining the grant date, estimating the fair value of the awards, and the timing and recognition of related expenses. These estimates have a material impact on our results of operations.

For both employee and nonemployee awards, the grant date is determined based on the date of final Board approval of the award, in accordance with ASC 718. The fair value of stock awards is generally determined based on the market price of our common stock on the grant date. For awards where the grant date has not yet been established but the service inception date has commenced, we accrue compensation expense based on the estimated fair value of our common stock at the end of each reporting period, which may introduce variability in the reported compensation expense.

As of December 31, 2025 and June 30, 2025, we recorded accrued compensation costs related to these arrangements of $264,546 and $89,165, respectively.

In certain instances, we issue fully vested, nonforfeitable share-based awards to nonemployees prior to receiving the goods or services, resulting in the recognition of prepaid share-based compensation. These awards are accounted for under ASC 718-10-45-3 and are recorded as prepaid assets when issued, with expense recognized as the goods or services are received. The fair value of such awards is determined at the grant date, based on the market price of our common stock.

We recognize share-based compensation expense over the requisite service period for employees, and the vesting period for nonemployees, in accordance with ASC 718. Our policy is to recognize forfeitures as they occur, rather than estimating forfeitures at the grant date, which may result in increased volatility in compensation expense.

During the six months ended December 31, 2025 and 2024, we recognized total share-based compensation expense as follows:

	December 31, 2025		December 31, 2024

Nonemployees	$	601,983	$	545,859
Employee		118,065		201,680
Director		16,691		-
Total	$	736,739	$	747,539

The fair value of our common stock, particularly in periods of volatility, is a key source of estimation uncertainty. Changes in assumptions or market conditions could significantly impact the fair value of awards and the related compensation expense.

Table of Contents

6. Deferred Taxes and Valuation Allowance

We assess the realizability of deferred tax assets by evaluating both positive and negative evidence, including future taxable income, tax planning strategies, and recent financial performance. If it is more likely than not that some or all of the deferred tax assets will not be realized, a valuation allowance is recorded.

Judgment is required to estimate future taxable income and assess the impact of economic trends or changes in tax law. Adjustments to valuation allowances could materially impact our income tax expense or benefit.

We believe the estimates and assumptions used in preparing our consolidated financial statements are reasonable and appropriate. However, actual results could differ materially from those estimates, which could have a significant impact on our financial condition, results of operations, and cash flows.

Working Capital

As of December 31, 2025, we had cash and cash equivalents of $2,025,854, representing an increase of $1,004,742, or 98.4%, compared to $1,021,112 as of June 30, 2025, respectively. Deposits with banks decreased by $276,484, or 21.7%, from $1,276,484 as of June 30, 2025, to $1,000,000 as of December 31, 2025. The remaining $1,000,000 held in a certificate of deposit account is scheduled to mature in March 2026. Our accumulated operating losses increased by $1,850,931, or approximately 10%, from $18,263,181 as of June 30, 2025, to $20,114,112 as of December 31, 2025. In October, 2025, we raised gross proceeds of $2,000,000 in the Offering with Ergon. We believe that the successful completion of the Offering has improved our liquidity and financial position for the near term. We expect to seek funding for our operations over the next twelve months through additional public and private offerings of our securities, including a potential listing of our common stock on a national exchange and concurrent public offering.

Our primary source of cash is currently generated from the sale of our securities. We will need to raise additional funds beyond our current working capital balance in order to finance future development of our products and services until such time as future revenues are achieved. We anticipate generating revenue in the future from the Ergon License; however, there can be no assurances that sufficient revenue will be generated or that revenues, if any are achieved, will be sufficient to fund our operations on a profitable basis, particularly given our negotiated 15 month “go to market” period with Ergon.

As we continue to make progress commercially, we believe we will have potential opportunities to strengthen our balance sheet as needed including, but not limited to, debt and/or equity financing, as well as through additional potential licensing arrangements. All of these financing options should provide our company with the flexibility as we continue to drive shareholder value. However, we may not be able to obtain financing on favorable terms when needed, or at all. Our ability to obtain additional financing will be subject to a number of factors, including market conditions, fluctuations in interest rates, our operating performance and investor sentiment. If we are unable to raise additional capital when required or on acceptable terms, we may have to significantly delay or scale back our operations or obtain funds by entering into agreements on unfavorable terms. Failure to obtain additional capital on acceptable terms, or at all, would result in a material and adverse impact on our operations.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors.

Table of Contents

ITEM 3: Quantitative and Qualitative Disclosure About Market Risk

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

ITEM 4: Controls and Procedures

Disclosure Controls and Procedures

Under the supervision and with the participation of our senior management, including our principal executive officer and principal financial officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Quarterly Report. We are continuing to enhance our internal control environment; however, as a smaller reporting company with limited personnel, we have identified certain material weaknesses that require further remediation. These include (1) constraints inherent in a small finance team that impact segregation of duties, (2) the need for additional formalization and documentation of accounting policies, procedures, and review controls, (3) the need to further strengthen U.S. GAAP and SEC reporting expertise within the finance function, (4) the absence of an internal audit function to independently assess and monitor the effectiveness of internal controls, and (5) the lack of a functioning audit committee to provide appropriate oversight of the financial reporting and internal control process. Our management has already initiated enhancements to address these matters, including implementing additional review procedures, engaging external advisors where appropriate, and evaluating further changes to our internal control structure. We will continue to prioritize remediation efforts as resources permit.

Changes in Internal Control over Financial Reporting

During the six months ended December 31, 2025, we have continued to progressively develop and improve on the implementation of internal controls over financial reporting particularly in view of the material weakness described above.

Inherent Limitations of Controls

Internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP. Because of inherent limitations, internal controls may not prevent or detect all misstatements. In addition, the design, implementation, and effectiveness of controls may be affected by changes in conditions over time. Accordingly, even effective internal controls can provide only reasonable, not absolute, assurance that the objectives of the control system will be achieved.

Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may be subject to legal proceedings, investigations and claims incidental to the conduct of our business.

We are not a party to, nor are we aware of, any legal proceedings, investigations or claims which, in the opinion of our management, are likely to have a material adverse effect on our business, financial condition or results of operations.

Item 1A. Risk Factors

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item. Our current risk factors are set forth in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025, filed with the SEC on October 23, 2025.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

During the three month period ended December 31, 2025, we did not conduct any unregistered sales of equity securities other than those reported on our previous Current Reports on Form 8-K.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine and Safety Disclosure

Not applicable.

Item 5. Other Information

No director or Section 16 officer adopted or terminated a trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a “non-Rule 10b5-1” trading arrangement during the periods reported in this Quarterly Report.

Table of Contents

Item 6. Exhibits

The following is a complete list of exhibits filed or furnished, as applicable, as part of this Quarterly Report on Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.

Exhibit		Description
3.1		Amended Articles of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Annual Report on Form 10-K, filed with the SEC on October 23, 2025).
3.2		Amended and Revised Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 of the Registrant’s Quarterly Report on Form 10-Q for the period ended September 30, 2025, filed with the SEC on November 19, 2025).
4.1		Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on November 4, 2025).
10.1#†		License Agreement dated October 10, 2025, by and between Verde Renewables, Inc. and Ergon Asphalt & Emulsions, Inc. (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on October 14, 2025).
10.2†		Addendum to Joint Development Agreement, effective October 8, 2025, between Verde Resources, Inc. and C-Twelve Pty Ltd. (incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on October 14, 2025).
10.3		Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on November 4, 2025).
31.1*		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*	Filed herewith.
**	Furnished herewith.
#	Certain annexes, schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.
†	Certain portions of this exhibit (indicated by “[*]”) have been omitted pursuant to Item 601(a)(6) of Regulation S-K.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 17, 2026	VERDE RESOURCES, INC.

	By:	/s/ Jack Wong
		Jack Wong
		Chief Executive Officer (Principal Executive Officer)

	By:	/s/ Sherina Chui
		Sherina Chui
		Chief Financial Officer (Principal Financial and Accounting Officer)

VERDE RESOURCES, INC. 10-Q